UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549	OMB APPROVAL
	OMB Number:  3235-0582
	Expires:  July 31, 2024
	Estimated average burden
	hours per response........4

FORM N-PX

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number  811- 06565

Tekla World Healthcare Fund

(Exact name of registrant as specified in charter)

100 Federal Street, 19th Floor, Boston, MA	02110
(Address of principal executive offices)	(Zip code)

Laura Woodward

Tekla World Healthcare Fund

100 Federal Street, 19^th Floor, Boston MA 02110

(Name and address of agent for service)

Registrant’s telephone number, including area code:  617-772-8500

Date of fiscal year end:  September 30

Date of reporting period:  7/1/21-6/30/22

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

Item 1. Proxy Voting Record.

Vote Summary 

1LIFE HEALTHCARE, INC.

Security	68269G107	Meeting Type	Special
Ticker Symbol	ONEM	Meeting Date	27-Aug-2021
Record Date	13-Jul-2021

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To approve the issuance of shares of common stock, $0.001 par value per share, of 1Life Healthcare, Inc. to stockholders of Iora Health, Inc. in connection with the merger contemplated by the Agreement and Plan of Merger, dated June 6, 2021, among 1Life Healthcare, Inc., SB Merger Sub, Inc., Iora Health, Inc. and Fortis Advisors LLC, solely in its capacity as the representative of the stockholders of Iora.	Management	For	For
2.	To approve adjournments of the 1Life special meeting, if necessary and appropriate, to solicit additional proxies if there are not sufficient votes to approve the 1Life stock issuance proposal.	Management	For	For

1LIFE HEALTHCARE, INC.

Security	68269G107	Meeting Type	Annual
Ticker Symbol	ONEM	Meeting Date	02-Jun-2022
Record Date	04-Apr-2022

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1	Paul R. Auvil		For	For
	2	Mark S. Blumenkranz, MD		For	For
	3	Kalen F. Holmes, Ph.D.		For	For
2.	To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022.		Management	For	For
3.	To approve, on a non-binding advisory basis, the compensation of our named executive officers.		Management	For	For
4.	To approve, on a non-binding advisory basis, the frequency of future non-binding stockholder advisory votes on the compensation of our named executive officers.		Management	1 Year	For

ABBOTT LABORATORIES

Security	002824100	Meeting Type	Annual
Ticker Symbol	ABT	Meeting Date	29-Apr-2022
Record Date	02-Mar-2022

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1.	R. J. Alpern		For	For
	2.	S. E. Blount		For	For
	3.	R. B. Ford		For	For
	4.	P. Gonzalez		For	For
	5.	M. A. Kumbier		For	For
	6.	D. W. McDew		For	For
	7.	N. McKinstry		For	For
	8.	W. A. Osborn		For	For
	9.	M. F. Roman		For	For
	10.	D. J. Starks		For	For
	11.	J. G. Stratton		For	For
	12.	G. F. Tilton		For	For
2.	Ratification of Ernst & Young LLP As Auditors		Management	For	For
3.	Say on Pay - An Advisory Vote on the Approval of Executive Compensation		Management	For	For
4.	Shareholder Proposal - Special Shareholder Meeting Threshold		Shareholder	Against	For
5.	Shareholder Proposal - Independent Board Chairman		Shareholder	For	Against
6.	Shareholder Proposal - Rule 10b5-1 Plans		Shareholder	Against	For
7.	Shareholder Proposal - Lobbying Disclosure		Shareholder	Against	For
8.	Shareholder Proposal - Antimicrobial Resistance Report		Shareholder	Against	For

ABBVIE INC.

Security	00287Y109	Meeting Type	Annual
Ticker Symbol	ABBV	Meeting Date	06-May-2022
Record Date	07-Mar-2022

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1.	William H.L. Burnside		For	For
	2.	Thomas C. Freyman		For	For
	3.	Brett J. Hart		For	For
	4.	Edward J. Rapp		For	For
2.	Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2022		Management	For	For
3.	Say on Pay - An advisory vote on the approval of executive compensation		Management	For	For
4.	Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting		Management	For	For
5.	Stockholder Proposal - to Adopt a Policy to Require Independent Chairman		Shareholder	For	Against
6.	Stockholder Proposal - to Seek Shareholder Approval of Certain Termination Pay Arrangements		Shareholder	Against	For
7.	Stockholder Proposal - to Issue a Report on Board Oversight of Competition Practices		Shareholder	Against	For
8.	Stockholder Proposal - to Issue an Annual Report on Political Spending		Shareholder	Against	For

AFFIMED N.V

Security	N01045108	Meeting Type	Annual
Ticker Symbol	AFMD	Meeting Date	22-Jun-2022
Record Date	25-May-2022

Item	Proposal	Proposed by	Vote	For/Against Management
3.	Adoption of the Statutory Annual Accounts for the financial year 2021	Management	For	For
4.	Discharge of the managing directors for their management during the financial year 2021	Management	For	For
5.	Discharge of the supervisory directors for their supervision during the financial year 2021	Management	For	For
6b.	Amendment of the Remuneration Policy for the Management Board	Management	For	For
6c.	Amendment of the Remuneration Policy for the Supervisory Board	Management	For	For
7.	Reappointment of Dr. Bernhard Ehmer as a supervisory director	Management	For	For
8.	Appointment of the auditor for the financial year 2022	Management	For	For
9.	Authorization to acquire shares	Management	For	For

ALERISLIFE, INC.

Security	33832D205	Meeting Type	Annual
Ticker Symbol	ALR	Meeting Date	07-Jun-2022
Record Date	22-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Jennifer B. Clark (for Managing Director in Group III)	Management	For	For
1.2	Election of Director: Bruce M. Gans, M.D. (for Independent Director in Group III)	Management	For	For
1.3	Election of Director: Michael E. Wagner, M.D. (for Independent Director in Group III)	Management	For	For
2.	Approval of the Second Amended and Restated 2014 Equity Compensation Plan.	Management	For	For
3.	Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2022 fiscal year.	Management	For	For

ALIGN TECHNOLOGY, INC.

Security	016255101	Meeting Type	Annual
Ticker Symbol	ALGN	Meeting Date	18-May-2022
Record Date	23-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Kevin J. Dallas	Management	For	For
1b.	Election of Director: Joseph M. Hogan	Management	For	For
1c.	Election of Director: Joseph Lacob	Management	For	For
1d.	Election of Director: C. Raymond Larkin, Jr.	Management	For	For
1e.	Election of Director: George J. Morrow	Management	For	For
1f.	Election of Director: Anne M. Myong	Management	For	For
1g.	Election of Director: Andrea L. Saia	Management	For	For
1h.	Election of Director: Greg J. Santora	Management	For	For
1i.	Election of Director: Susan E. Siegel	Management	For	For
1j.	Election of Director: Warren S. Thaler	Management	For	For
2.	RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2022.	Management	For	For
3.	ADVISORY VOTE ON NAMED EXECUTIVES COMPENSATION: Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers.	Management	For	For

AMGEN, INC.

Security	031162100	Meeting Type	Annual
Ticker Symbol	AMGN	Meeting Date	17-May-2022
Record Date	18-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director for a term of expiring at the 2023 annual meeting: Dr. Wanda M. Austin	Management	For	For
1B.	Election of Director for a term of expiring at the 2023 annual meeting: Mr. Robert A. Bradway	Management	For	For
1C.	Election of Director for a term of expiring at the 2023 annual meeting: Dr. Brian J. Druker	Management	For	For
1D.	Election of Director for a term of expiring at the 2023 annual meeting: Mr. Robert A. Eckert	Management	For	For
1E.	Election of Director for a term of expiring at the 2023 annual meeting: Mr. Greg C. Garland	Management	For	For
1F.	Election of Director for a term of expiring at the 2023 annual meeting: Mr. Charles M. Holley, Jr.	Management	For	For
1G.	Election of Director for a term of expiring at the 2023 annual meeting: Dr. S. Omar Ishrak	Management	For	For
1H.	Election of Director for a term of expiring at the 2023 annual meeting: Dr. Tyler Jacks	Management	For	For
1I.	Election of Director for a term of expiring at the 2023 annual meeting: Ms. Ellen J. Kullman	Management	For	For
1J.	Election of Director for a term of expiring at the 2023 annual meeting: Ms. Amy E. Miles	Management	For	For
1K.	Election of Director for a term of expiring at the 2023 annual meeting: Dr. Ronald D. Sugar	Management	For	For
1L.	Election of Director for a term of expiring at the 2023 annual meeting: Dr. R. Sanders Williams	Management	For	For
2.	Advisory vote to approve our executive compensation.	Management	For	For
3.	To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2022.	Management	For	For

ANTHEM, INC.

Security	036752103	Meeting Type	Annual
Ticker Symbol	ANTM	Meeting Date	18-May-2022
Record Date	17-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Susan D. DeVore	Management	For	For
1.2	Election of Director: Bahija Jallal	Management	For	For
1.3	Election of Director: Ryan M. Schneider	Management	For	For
1.4	Election of Director: Elizabeth E. Tallett	Management	For	For
2.	Advisory vote to approve the compensation of our named executive officers.	Management	For	For
3.	To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2022.	Management	For	For
4.	To approve an amendment to our Articles of Incorporation to change our name to Elevance Health, Inc.	Management	For	For
5.	Shareholder proposal to prohibit political funding.	Shareholder	Against	For
6.	Shareholder proposal requesting a racial impact audit and report.	Shareholder	Against	For

ARDELYX, INC.

Security	039697107	Meeting Type	Annual
Ticker Symbol	ARDX	Meeting Date	13-Jul-2022
Record Date	25-Apr-2022

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1.	Geoffrey A. Block, M.D.		For	For
	2.	David Mott		For	For
	3.	Michael Raab		For	For
2.	To grant our Board of Directors authority to effect a reverse stock split of our authorized common stock and issued and outstanding common stock by amending our Amended and Restated Certificate of Incorporation by September 15, 2022 and within a range of not less than 1-for-2 and not more than 1-for-10, if our Board of Directors deems it within our best interests.		Management	For	For
3.	To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2022.		Management	For	For
4.	To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on- Pay").		Management	For	For

ARGENX SE

Security	04016X101	Meeting Type	Annual
Ticker Symbol	ARGX	Meeting Date	10-May-2022
Record Date	20-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
3.	Advisory vote to approve the 2021 remuneration report	Management	For
4b.	Adoption of the 2021 annual accounts	Management	For
4d.	Allocation of losses of the Company in the financial year 2021 to the retained earnings of the Company	Management	For
4e.	Proposal to release the members of the board of directors from liability for their respective duties carried out in the financial year 2021	Management	For
5.	Re-appointment of Tim Van Hauwermeiren as executive director to the board of directors of the Company for a term of 4 years	Management	For
6.	Re-appointment of Peter Verhaeghe as non-executive director to the board of directors of the Company for a term of 2 years	Management	For
7.	Re-appointment of James Daly as non-executive director to the board of directors of the Company for a term of 4 years	Management	For
8.	Re-appointment of Werner Lanthaler as non-executive director to the board of directors of the Company for a term of 2 years	Management	For
9.	Authorization of the board of directors to issue shares and grant rights to subscribe for shares in the share capital of the Company up to a maximum of 10% of the outstanding capital at the date of the general meeting, for a period of 18 months from the annual general meeting and to limit or exclude statutory pre-emptive rights, if any.	Management	For
10.	Amendment of the articles of association of argenx SE to align with current Dutch law and practice and to grant proxy to each of the directors of the Company and employees of Freshfields Bruckhaus Deringer LLP in having the deed of amendment executed	Management	For
11.	Appointment of Deloitte Accountants B.V. as statutory auditor for the 2022 financial year.	Management	For

ASTELLAS PHARMA, INC.

Security	J03393105	Meeting Type	Annual General Meeting
Ticker Symbol	4503 JP	Meeting Date	20-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1.	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations	Management	For	For
2.1	Appoint a Director who is not Audit and Supervisory Committee Member Yasukawa, Kenji	Management	For	For
2.2	Appoint a Director who is not Audit and Supervisory Committee Member Okamura, Naoki	Management	For	For
2.3	Appoint a Director who is not Audit and Supervisory Committee Member Sekiyama, Mamoru	Management	For	For
2.4	Appoint a Director who is not Audit and Supervisory Committee Member Kawabe, Hiroshi	Management	For	For
2.5	Appoint a Director who is not Audit and Supervisory Committee Member Tanaka, Takashi	Management	For	For
2.6	Appoint a Director who is not Audit and Supervisory Committee Member Sakurai, Eriko	Management	For	For
3.1	Appoint a Director who is Audit and Supervisory Committee Member Yoshimitsu, Toru	Management	For	For
3.2	Appoint a Director who is Audit and Supervisory Committee Member Takahashi, Raita	Management	For	For
3.3	Appoint a Director who is Audit and Supervisory Committee Member Nakayama, Mika	Management	For	For

ASTRAZENECA PLC

Security	046353108	Meeting Type	Annual
Ticker Symbol	AZN	Meeting Date	29-Apr-2022
Record Date	07-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2021	Management	For	For
2.	To confirm dividends	Management	For	For
3.	To reappoint PricewaterhouseCoopers LLP as Auditor	Management	For	For
4.	To authorise the Directors to agree the remuneration of the Auditor	Management	For	For
5A.	Re-election of Director: Leif Johansson	Management	For	For
5B.	Re-election of Director: Pascal Soriot	Management	For	For
5C.	Election of Director: Aradhana Sarin	Management	For	For
5D.	Re-election of Director: Philip Broadley	Management	For	For
5E.	Re-election of Director: Euan Ashley	Management	For	For
5F.	Re-election of Director: Michel Demaré	Management	For	For
5G.	Re-election of Director: Deborah DiSanzo	Management	For	For
5H.	Re-election of Director: Diana Layfield	Management	For	For
5I.	Re-election of Director: Sheri McCoy	Management	For	For
5J.	Re-election of Director: Tony Mok	Management	For	For
5K.	Re-election of Director: Nazneen Rahman	Management	For	For
5L.	Election of Director: Andreas Rummelt	Management	For	For
5M.	Re-election of Director: Marcus Wallenberg	Management	For	For
6.	To approve the Annual Report on Remuneration for the year ended 31 December 2021	Management	For	For
7.	To authorise limited political donations	Management	For	For
8.	To authorise the Directors to allot shares	Management	For	For
9.	To authorise the Directors to disapply pre-emption rights (Special Resolution)	Management	For	For
10.	To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution)	Management	For	For
11.	To authorise the Company to purchase its own shares (Special Resolution)	Management	For	For
12.	To reduce the notice period for general meetings (Special Resolution)	Management	For	For
13.	To extend the AstraZenca PLC 2012 Savings Related Share Option Scheme	Management	For	For

BAYER AG

Security	D0712D163	Meeting Type	Annual General Meeting
Ticker Symbol	BAYN GR	Meeting Date	29-Apr-2022
Record Date	22-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	DISTRIBUTION OF THE PROFIT	Management	For	For
2.	RATIFICATION OF THE ACTIONS OF THE MEMBERS OF THE BOARD OF MANAGEMENT	Management	For	For
3.	RATIFICATION OF THE ACTIONS OF THE MEMBERS OF THE SUPERVISORY BOARD	Management	For	For
4.1	SUPERVISORY BOARD ELECTION: DR. PAUL ACHLEITNER	Management	For	For
4.2	SUPERVISORY BOARD ELECTION: DR. NORBERT W. BISCHOFBERGER	Management	For	For
4.3	SUPERVISORY BOARD ELECTION: COLLEEN A. GOGGINS	Management	For	For
5.	APPROVAL OF THE COMPENSATION REPORT	Management	For	For
6.	APPROVAL OF THE CONTROL AND PROFIT AND LOSS TRANSFER AGREEMENT BETWEEN THE COMPANY AND BAYER CHEMICALS GMBH	Management	For	For
7.	RATIFY DELOITTE GMBH AS AUDITORS FOR FISCAL YEAR 2022	Management	For	For

BECTON, DICKINSON AND COMPANY

Security	075887109	Meeting Type	Annual
Ticker Symbol	BDX	Meeting Date	25-Jan-2022
Record Date	06-Dec-2021

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Catherine M. Burzik	Management	For	For
1B.	Election of Director: Carrie L. Byington	Management	For	For
1C.	Election of Director: R. Andrew Eckert	Management	For	For
1D.	Election of Director: Claire M. Fraser	Management	For	For
1E.	Election of Director: Jeffrey W. Henderson	Management	For	For
1F.	Election of Director: Christopher Jones	Management	For	For
1G.	Election of Director: Marshall O. Larsen	Management	For	For
1H.	Election of Director: David F. Melcher	Management	For	For
1I.	Election of Director: Thomas E. Polen	Management	For	For
1J.	Election of Director: Claire Pomeroy	Management	For	For
1K.	Election of Director: Timothy M. Ring	Management	For	For
1L.	Election of Director: Bertram L. Scott	Management	For	For
2.	Ratification of the selection of the independent registered public accounting firm.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	A shareholder proposal seeking to lower the ownership threshold required to call a special shareholders meeting, if properly presented at the meeting.	Shareholder	Against	For

BEIGENE LTD

Security	07725L102	Meeting Type	Annual
Ticker Symbol	BGNE	Meeting Date	22-Jun-2022
Record Date	18-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	THAT Anthony C. Hooper be and is hereby re-elected to serve as a Class III director of the Company until the 2025 annual general meeting of the shareholders of the Company and until his successor is duly elected and qualified, subject to his earlier resignation or removal.	Management	For	For
2.	THAT Ranjeev Krishana be and is hereby re-elected to serve as a Class III director of the Company until the 2025 annual general meeting of the shareholders of the Company and until his successor is duly elected and qualified, subject to his earlier resignation or removal.	Management	For	For
3.	THAT Xiaodong Wang be and is hereby re-elected to serve as a Class III director of the Company until the 2025 annual general meeting of the shareholders of the Company and until his successor is duly elected and qualified, subject to his earlier resignation or removal.	Management	For	For
4.	THAT Qingqing Yi be and is hereby re-elected to serve as a Class III director until the 2025 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal.	Management	For	For
5.	THAT Margaret Dugan be and is hereby re-elected to serve as a Class I director until the 2023 annual general meeting of shareholders and until her successor is duly elected and qualified, subject to her earlier resignation or removal.	Management	For	For
6.	THAT Alessandro Riva be and is hereby re-elected to serve as a Class I director until the 2023 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal.	Management	For	For
7.	THAT the selection of Ernst & Young LLP, Ernst & Young Hua Ming LLP and Ernst & Young as the Company's reporting accounting firms for the fiscal year ending December 31, 2022 be and is hereby approved, ratified and confirmed.	Management	For	For
8.	THAT the granting of a share issue mandate to the Board of ...(due to space limits, see proxy material for full proposal).	Management	For	For
9.	THAT the granting of a share repurchase mandate to the Board of ...(due to space limits, see proxy material for full proposal).	Management	For	For
10.	THAT the Company and its underwriters be and are hereby ...(due to space limits, see proxy material for full proposal).	Management	For	For
11.	THAT the Company and its underwriters be and are hereby ...(due to space limits, see proxy material for full proposal).	Management	For	For
12.	THAT the grant of an option to acquire shares to Amgen to allow ...(due to space limits, see proxy material for full proposal).	Management	For	For
13.	THAT the grant of restricted share units ("RSUs") with a grant ...(due to space limits, see proxy material for full proposal).	Management	For	For
14.	THAT the grant of RSUs with a grant date fair value of ...(due to space limits, see proxy material for full proposal).	Management	For	For
15.	THAT the grant of RSUs with a grant date fair value of ...(due to space limits, see proxy material for full proposal).	Management	For	For
16.	THAT the Amendment No. 2 to the 2016 Plan to increase the number ...(due to space limits, see proxy material for full proposal).	Management	For	For
17.	THAT, on a non-binding, advisory basis, the compensation of the ...(due to space limits, see proxy material for full proposal).	Management	For	For
18.	THAT the adjournment of the Annual Meeting by the chairman, if ...(due to space limits, see proxy material for full proposal).	Management	For	For

BIOGEN, INC.

Security	09062X103	Meeting Type	Annual
Ticker Symbol	BIIB	Meeting Date	15-Jun-2022
Record Date	21-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Alexander J. Denner	Management	For	For
1b.	Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Caroline D. Dorsa	Management	For	For
1c.	Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Maria C. Freire	Management	For	For
1d.	Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: William A. Hawkins	Management	For	For
1e.	Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: William D. Jones	Management	For	For
1f.	Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Jesus B. Mantas	Management	For	For
1g.	Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Richard C. Mulligan	Management	For	For
1h.	Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Stelios Papadopoulos	Management	For	For
1i.	Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Eric K. Rowinsky	Management	For	For
1j.	Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Stephen A. Sherwin	Management	For	For
1k.	Election of Director to serve for a one-year term extending until the 2023 Annual Meeting: Michel Vounatsos	Management	For	For
2.	To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2022.	Management	For	For
3.	Say on Pay - To approve an advisory vote on executive compensation.	Management	For	For

BIOHAVEN PHARMACEUTICAL HLDG CO LTD

Security	G11196105	Meeting Type	Annual
Ticker Symbol	BHVN	Meeting Date	28-Apr-2022
Record Date	02-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director for a term expiring at the 2025 Annual Meeting: John W. Childs	Management	For	For
1B.	Election of Director for a term expiring at the 2025 Annual Meeting: Gregory H. Bailey	Management	For	For
1C.	Election of Director for a term expiring at the 2025 Annual Meeting: Kishan Mehta	Management	For	For
2.	Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2022.	Management	For	For
3.	To approve, on a non-binding advisory basis, the compensation of the Named Executive Officers.	Management	For	For

BOSTON SCIENTIFIC CORPORATION

Security	101137107	Meeting Type	Annual
Ticker Symbol	BSX	Meeting Date	05-May-2022
Record Date	11-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Nelda J. Connors	Management	For	For
1B.	Election of Director: Charles J. Dockendorff	Management	For	For
1C.	Election of Director: Yoshiaki Fujimori	Management	For	For
1D.	Election of Director: Donna A. James	Management	For	For
1E.	Election of Director: Edward J. Ludwig	Management	For	For
1F.	Election of Director: Michael F. Mahoney	Management	For	For
1G.	Election of Director: David J. Roux	Management	For	For
1H.	Election of Director: John E. Sununu	Management	For	For
1I.	Election of Director: David S. Wichmann	Management	For	For
1J.	Election of Director: Ellen M. Zane	Management	For	For
2.	To approve, on a non-binding, advisory basis, named executive officer compensation.	Management	For	For
3.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2022 fiscal year.	Management	For	For
4.	To approve an amendment and restatement of our 2006 Global Employee Stock Ownership Plan (to be renamed as our Employee Stock Purchase Plan), as previously amended and restated, including a request for 10,000,000 additional shares.	Management	For	For

BRISTOL-MYERS SQUIBB COMPANY

Security	110122108	Meeting Type	Annual
Ticker Symbol	BMY	Meeting Date	03-May-2022
Record Date	14-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A)	Election of Director: Peter J. Arduini	Management	For	For
1B)	Election of Director: Giovanni Caforio, M.D.	Management	For	For
1C)	Election of Director: Julia A. Haller, M.D.	Management	For	For
1D)	Election of Director: Manuel Hidalgo Medina, M.D., Ph.D.	Management	For	For
1E)	Election of Director: Paula A. Price	Management	For	For
1F)	Election of Director: Derica W. Rice	Management	For	For
1G)	Election of Director: Theodore R. Samuels	Management	For	For
1H)	Election of Director: Gerald L. Storch	Management	For	For
1I)	Election of Director: Karen H. Vousden, Ph.D.	Management	For	For
1J)	Election of Director: Phyllis R. Yale	Management	For	For
2.	Advisory Vote to Approve the Compensation of our Named Executive Officers.	Management	For	For
3.	Ratification of the Appointment of an Independent Registered Public Accounting Firm.	Management	For	For
4.	Shareholder Proposal to Lower the Ownership Threshold for Special Shareholder Meetings to 10%.	Shareholder	Against	For
5.	Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director.	Shareholder	For	Against

CHARLES RIVER LABORATORIES INTL., INC.

Security	159864107	Meeting Type	Annual
Ticker Symbol	CRL	Meeting Date	10-May-2022
Record Date	21-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: James C. Foster	Management	For	For
1B.	Election of Director: Nancy C. Andrews	Management	For	For
1C.	Election of Director: Robert Bertolini	Management	For	For
1D.	Election of Director: Deborah T. Kochevar	Management	For	For
1E.	Election of Director: George Llado, Sr.	Management	For	For
1F.	Election of Director: Martin W. MacKay	Management	For	For
1G.	Election of Director: George E. Massaro	Management	For	For
1H.	Election of Director: C. Richard Reese	Management	For	For
1I.	Election of Director: Richard F. Wallman	Management	For	For
1J.	Election of Director: Virginia M. Wilson	Management	For	For
2.	Advisory approval of 2021 Executive Compensation	Management	For	For
3.	Ratification of PricewaterhouseCoopers LLC as independent registered accounting public firm for 2022	Management	For	For

CIGNA CORPORATION

Security	125523100	Meeting Type	Annual
Ticker Symbol	CI	Meeting Date	27-Apr-2022
Record Date	08-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: David M. Cordani	Management	For	For
1B.	Election of Director: William J. DeLaney	Management	For	For
1C.	Election of Director: Eric J. Foss	Management	For	For
1D.	Election of Director: Elder Granger, MD, MG, USA (Retired)	Management	For	For
1E.	Election of Director: Neesha Hathi	Management	For	For
1F.	Election of Director: George Kurian	Management	For	For
1G.	Election of Director: Kathleen M. Mazzarella	Management	For	For
1H.	Election of Director: Mark B. McClellan, MD, PhD	Management	For	For
1I.	Election of Director: Kimberly A. Ross	Management	For	For
1J.	Election of Director: Eric C. Wiseman	Management	For	For
1K.	Election of Director: Donna F. Zarcone	Management	For	For
2.	Advisory approval of Cigna's executive compensation.	Management	For	For
3.	Ratification of the appointment of PricewaterhouseCoopers LLP as Cigna's independent registered public accounting firm for 2022.	Management	For	For
4.	Shareholder proposal - Special shareholder meeting improvement.	Shareholder	Against	For
5.	Shareholder proposal - Gender pay gap report.	Shareholder	Against	For
6.	Shareholder proposal - Political contributions report.	Shareholder	Against	For

COMMUNITY HEALTH SYSTEMS, INC.

Security	203668108	Meeting Type	Annual
Ticker Symbol	CYH	Meeting Date	10-May-2022
Record Date	14-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Susan W. Brooks	Management	For	For
1B.	Election of Director: John A. Clerico	Management	For	For
1C.	Election of Director: Michael Dinkins	Management	For	For
1D.	Election of Director: James S. Ely III	Management	For	For
1E.	Election of Director: John A. Fry	Management	For	For
1F.	Election of Director: Joseph A. Hastings, D.M.D.	Management	For	For
1G.	Election of Director: Tim L. Hingtgen	Management	For	For
1H.	Election of Director: Elizabeth T. Hirsch	Management	For	For
1I.	Election of Director: William Norris Jennings, M.D.	Management	For	For
1J.	Election of Director: K. Ranga Krishnan, MBBS	Management	For	For
1K.	Election of Director: Wayne T. Smith	Management	For	For
1L.	Election of Director: H. James Williams, Ph.D.	Management	For	For
2.	Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.	Management	For	For
3.	Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.	Management	For	For

COMMUNITY HEALTHCARE TRUST INCORPORATED

Security	20369C106	Meeting Type	Annual
Ticker Symbol	CHCT	Meeting Date	05-May-2022
Record Date	04-Mar-2022

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1.	Cathrine Cotman		For	For
	2.	Alan Gardner		For	For
	3.	Claire Gulmi		For	For
	4.	Robert Hensley		For	For
	5.	Lawrence Van Horn		For	For
	6.	Timothy Wallace		For	For
2.	To approve, on a non-binding advisory basis, the following resolutions: RESOLVED, that the stockholders of Community Healthcare Trust Incorporated approve, on a non-binding advisory basis, the compensation of the named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2022 annual meeting of stockholders.		Management	For	For
3.	To ratify the appointment of BDO USA, LLP as the Company's independent registered public accountants for 2022.		Management	For	For

CSL LTD

Security	Q3018U109	Meeting Type	Annual General Meeting
Ticker Symbol	CSL AU	Meeting Date	12-Oct-2021
Record Date	08-Oct-2021

Item	Proposal	Proposed by	Vote	For/Against Management
2.A	TO RE-ELECT DR BRIAN MCNAMEE AO AS A DIRECTOR	Management	For	For
2.B	TO RE-ELECT PROFESSOR ANDREW CUTHBERTSON AO AS A DIRECTOR	Management	For	For
2.C	TO ELECT MS ALISON WATKINS AS A DIRECTOR	Management	For	For
2.D	TO ELECT PROFESSOR DUNCAN MASKELL AS A DIRECTOR	Management	For	For
3.	ADOPTION OF THE REMUNERATION REPORT	Management	For	For
4.	APPROVAL OF A GRANT OF PERFORMANCE SHARE UNITS TO THE CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR, MR PAUL PERREAULT	Management	For	For
5.	RENEWAL OF PROPORTIONAL TAKEOVER APPROVAL PROVISIONS IN CONSTITUTION	Management	For	For

CVS HEALTH CORPORATION

Security	126650100	Meeting Type	Annual
Ticker Symbol	CVS	Meeting Date	11-May-2022
Record Date	14-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Fernando Aguirre	Management	For	For
1B.	Election of Director: C. David Brown II	Management	For	For
1C.	Election of Director: Alecia A. DeCoudreaux	Management	For	For
1D.	Election of Director: Nancy-Ann M. DeParle	Management	For	For
1E.	Election of Director: Roger N. Farah	Management	For	For
1F.	Election of Director: Anne M. Finucane	Management	For	For
1G.	Election of Director: Edward J. Ludwig	Management	For	For
1H.	Election of Director: Karen S. Lynch	Management	For	For
1I.	Election of Director: Jean-Pierre Millon	Management	For	For
1J.	Election of Director: Mary L. Schapiro	Management	For	For
1K.	Election of Director: William C. Weldon	Management	For	For
2.	Ratification of the appointment of our independent registered public accounting firm for 2022.	Management	For	For
3.	Say on Pay, a proposal to approve, on an advisory basis, the Company's executive compensation.	Management	For	For
4.	Stockholder proposal for reducing our ownership threshold to request a special stockholder meeting.	Shareholder	Against	For
5.	Stockholder proposal regarding our independent Board Chair.	Shareholder	For	Against
6.	Stockholder proposal on civil rights and non- discrimination audit focused on "non-diverse" employees.	Shareholder	Against	For
7.	Stockholder proposal requesting paid sick leave for all employees.	Shareholder	Against	For
8.	Stockholder proposal regarding a report on the public health costs of our food business to diversified portfolios.	Shareholder	Against	For

DAIICHI SANKYO COMPANY,LIMITED

Security	J11257102	Meeting Type	Annual General Meeting
Ticker Symbol	4568 JP	Meeting Date	27-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approve Appropriation of Surplus	Management	For	For
2.	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations	Management	For	For
3.1	Appoint a Director Manabe, Sunao	Management	For	For
3.2	Appoint a Director Hirashima, Shoji	Management	For	For
3.3	Appoint a Director Otsuki, Masahiko	Management	For	For
3.4	Appoint a Director Okuzawa, Hiroyuki	Management	For	For
3.5	Appoint a Director Uji, Noritaka	Management	For	For
3.6	Appoint a Director Kama, Kazuaki	Management	For	For
3.7	Appoint a Director Nohara, Sawako	Management	For	For
3.8	Appoint a Director Fukuoka, Takashi	Management	For	For
3.9	Appoint a Director Komatsu, Yasuhiro	Management	For	For
4.1	Appoint a Corporate Auditor Imazu, Yukiko	Management	For	For
4.2	Appoint a Corporate Auditor Matsumoto, Mitsuhiro	Management	For	For
5.	Approve Details of the Performance-based Stock Compensation to be received by Directors	Management	For	For

DANAHER CORPORATION

Security	235851102	Meeting Type	Annual
Ticker Symbol	DHR	Meeting Date	10-May-2022
Record Date	11-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Rainer M. Blair	Management	For	For
1B.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Linda Filler	Management	For	For
1C.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Teri List	Management	For	For
1D.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Walter G. Lohr, Jr.	Management	For	For
1E.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Jessica L. Mega, MD, MPH	Management	For	For
1F.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Mitchell P. Rales	Management	For	For
1G.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Steven M. Rales	Management	For	For
1H.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Pardis C. Sabeti, MD, D. PHIL	Management	For	For
1I.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: A. Shane Sanders	Management	For	For
1J.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: John T. Schwieters	Management	For	For
1K.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Alan G. Spoon	Management	For	For
1L.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Raymond C. Stevens, Ph.D	Management	For	For
1M.	Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Elias A. Zerhouni, MD	Management	For	For
2.	To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2022.	Management	For	For
3.	To approve on an advisory basis the Company's named executive officer compensation.	Management	For	For
4.	To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 10%.	Shareholder	Against	For

DENTSPLY SIRONA, INC.

Security	24906P109	Meeting Type	Annual
Ticker Symbol	XRAY	Meeting Date	25-May-2022
Record Date	28-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Eric K. Brandt	Management	For	For
1B.	Election of Director: Donald M. Casey Jr.	Management	For	For
1C.	Election of Director: Willie A. Deese	Management	For	For
1D.	Election of Director: John P. Groetelaars	Management	For	For
1E.	Election of Director: Betsy D. Holden	Management	For	For
1F.	Election of Director: Clyde R. Hosein	Management	For	For
1G.	Election of Director: Harry M. Kraemer Jr.	Management	For	For
1H.	Election of Director: Gregory T. Lucier	Management	For	For
1I.	Election of Director: Leslie F. Varon	Management	For	For
1J.	Election of Director: Janet S. Vergis	Management	For	For
1K.	Election of Director: Dorothea Wenzel	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accountants for 2022.	Management	For	For
3.	Approval, by non-binding vote, of the Company's executive compensation.	Management	For	For
4.	Approval of the Amendment to the Fifth Amended and Restated By- Laws to Designate the Exclusive Forum for the Adjudication of Certain Legal Matters.	Management	For	For

DEXCOM, INC.

Security	252131107	Meeting Type	Annual
Ticker Symbol	DXCM	Meeting Date	19-May-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Class II Director to hold office until our 2023 Annual Meeting: Steven R. Altman	Management	For	For
1.2	Election of Class II Director to hold office until our 2023 Annual Meeting: Barbara E. Kahn	Management	For	For
1.3	Election of Class II Director to hold office until our 2023 Annual Meeting: Kyle Malady	Management	For	For
1.4	Election of Class II Director to hold office until our 2023 Annual Meeting: Jay S. Skyler, MD, MACP	Management	For	For
2.	To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.	Management	For	For
3.	To hold a non-binding vote on an advisory resolution to approve executive compensation.	Management	For	For
4.	To approve the amendment and restatement of our Restated Certificate of Incorporation to (i) effect a 4:1 forward split of our Common Stock (the "Forward Stock Split") and (ii) increase the number of shares of authorized Common Stock to effectuate the Forward Stock Split.	Management	For	For

DIVERSIFIED HEALTHCARE TRUST

Security	25525P107	Meeting Type	Annual
Ticker Symbol	DHC	Meeting Date	02-Jun-2022
Record Date	22-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Independent Trustee: Lisa Harris Jones	Management	For	For
1B.	Election of Independent Trustee: John L. Harrington	Management	For	For
1C.	Election of Managing Trustee: Jennifer F. Francis	Management	For	For
1D.	Election of Managing Trustee: Adam D. Portnoy	Management	For	For
2.	Advisory vote to approve executive compensation.	Management	For	For
3.	Approval of the Amended and Restated 2012 Equity Compensation Plan.	Management	For	For
4.	Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2022 fiscal year.	Management	For	For

DYNACURE

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	09-Jul-2021
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the IPO of the Company and waiver of any rights under the Shareholders’ Agreement in connection with the IPO	Management	For	For

DYNACURE

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	06-Jan-2022
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Share capital increase by contribution in cash, of a nominal amount of 10,528.04 through the issuance of 263,201 new ordinary shares labelled C shares.	Management	For	For
2.	Cancellation of the preferential subscription right of the shareholders in favor of a named beneficiary.	Management	For	For
3.	Overall revision of the Company's by-laws, subject to the condition precedent of the completion of the capital increase covered by the first and second resolutions.	Management	For	For
4.	Delegation of authority to the Board of Directors to decide to increase the share capital with cancellation of the preferential subscription right, by a maximum nominal amount of 26,506 euros though the issuance of a maximum of 662,650 ABSA C with a nominal value of four euro cents (€0.04) each.	Management	For	For
5.	Cancellation of the preferential subscription right of the shareholders in favor of a named beneficiary.	Management	For	For
6.	Delegation of competence to be granted to the Board of Directors to decide the issuance and allocation of a maximum number of 642,789 shares outstanding.	Management	For	For
7.	Delegation of competence to be granted to the Board of Directors to decide the issuance and allocation of a maximum number of 642,789 BSA2022.	Management	For	For
8.	Cancellation of the shareholders’ preferential subscription right with respect to the BSA2022 in favor of determined categories of beneficiaries.	Management	For	For
9.	Delegation of competence granted to the Board of Directors to decide the issuance and allocation of 642,789 AGA2022.	Management	For	For
10.	Delegation of authority to the Board of Directors to increase the share capital by way of the issue of shares of the Company to participants in a company savings plan (plan d’épargne d’entreprise) established in accordance with articles L. 3332-1 et seq. of the French Labour Code.	Management	For	For
11.	Power to carry out formalities.	Management	For	For

DYNACURE

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	23-Jun-2022
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the annual financial statements for the fiscal year ended December 31, 2021 and discharge of the Chairman of the Board of Directors, the Chief Executive Officer, the Directors and the statutory auditors for the performance of their duties during the past fiscal year.	Management	For	For
2.	Allocation of the result for the fiscal year ended December 31, 2021.	Management	For	For
3.	Review of the agreements referred to in Articles L. 225-38 et seq. of the French Commercial Code.	Management	For	For
4.	Renewal of the terms of office of Bpifrance Investissement, Kurma Partners and Chris Mirabelli as directors.	Management	For	For
5.	Renewal of the terms of office of Ellen Hukkelhoven as observer.	Management	For	For
6.	Powers to carry out formalities.	Management	For	For

EDWARDS LIFESCIENCES CORPORATION

Security	28176E108	Meeting Type	Annual
Ticker Symbol	EW	Meeting Date	03-May-2022
Record Date	09-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Kieran T. Gallahue	Management	For	For
1.2	Election of Director: Leslie S. Heisz	Management	For	For
1.3	Election of Director: Paul A. LaViolette	Management	For	For
1.4	Election of Director: Steven R. Loranger	Management	For	For
1.5	Election of Director: Martha H. Marsh	Management	For	For
1.6	Election of Director: Michael A. Mussallem	Management	For	For
1.7	Election of Director: Ramona Sequeira	Management	For	For
1.8	Election of Director: Nicholas J. Valeriani	Management	For	For
2.	Advisory Vote to Approve Named Executive Officer Compensation	Management	For	For
3.	Ratification of Appointment of Independent Registered Public Accounting Firm	Management	For	For
4.	Stockholder Proposal for an Advisory Vote to Reduce the Share Ownership Threshold to Call a Special Meeting	Shareholder	Against	For

EISAI CO.,LTD.

Security	J12852117	Meeting Type	Annual General Meeting
Ticker Symbol	4523 JP	Meeting Date	17-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations, Approve Minor Revisions	Management	For	For
2.1	Appoint a Director Naito, Haruo	Management	For	For
2.2	Appoint a Director Kato, Yasuhiko	Management	For	For
2.3	Appoint a Director Kaihori, Shuzo	Management	For	For
2.4	Appoint a Director Uchiyama, Hideyo	Management	For	For
2.5	Appoint a Director Hayashi, Hideki	Management	For	For
2.6	Appoint a Director Miwa, Yumiko	Management	For	For
2.7	Appoint a Director Ike, Fumihiko	Management	For	For
2.8	Appoint a Director Kato, Yoshiteru	Management	For	For
2.9	Appoint a Director Miura, Ryota	Management	For	For
2.10	Appoint a Director Kato, Hiroyuki	Management	For	For
2.11	Appoint a Director Richard Thornley	Management	For	For

ELI LILLY AND COMPANY

Security	532457108	Meeting Type	Annual
Ticker Symbol	LLY	Meeting Date	02-May-2022
Record Date	22-Feb-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director to serve a three-year term: Ralph Alvarez	Management	For	For
1B.	Election of Director to serve a three-year term: Kimberly H. Johnson	Management	For	For
1C.	Election of Director to serve a three-year term: Juan R. Luciano	Management	For	For
2.	Approval, on an advisory basis, of the compensation paid to the company's named executive officers.	Management	For	For
3.	Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2022.	Management	For	For
4.	Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure.	Management	For	For
5.	Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions.	Management	For	For
6.	Approval of amendments to the company's Articles of Incorporation to give shareholders the ability to amend the company's bylaws.	Management	For	For
7.	Shareholder proposal to amend the bylaws to require an independent board chair.	Shareholder	For	Against
8.	Shareholder proposal to publish an annual report disclosing lobbying activities.	Shareholder	Against	For
9.	Shareholder proposal to disclose lobbying activities and alignment with public policy positions and statements.	Shareholder	Against	For
10.	Shareholder proposal to report oversight of risks related to anticompetitive pricing strategies.	Shareholder	Against	For

ENDEAVOR BIOMEDICINES, INC.

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	03-Mar-2022
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Amendment to Amended and Restated Certificate of Incorporation.	Management	For	For
2.	Amendment to Series B Preferred Stock Purchase Agreement.	Management	For	For
3.	General Authority and Ratification.	Management	For	For

GALERA THERAPEUTICS, INC.

Security	36338D108	Meeting Type	Annual
Ticker Symbol	GRTX	Meeting Date	15-Jun-2022
Record Date	22-Apr-2022

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1.	Emmett Cunningham		For	For
	2.	J. Mel Sorensen		For	For
2.	To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.		Management	For	For

GILEAD SCIENCES, INC.

Security	375558103	Meeting Type	Annual
Ticker Symbol	GILD	Meeting Date	04-May-2022
Record Date	15-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Jacqueline K. Barton, Ph.D.	Management	For	For
1B.	Election of Director: Jeffrey A. Bluestone, Ph.D.	Management	For	For
1C.	Election of Director: Sandra J. Horning, M.D.	Management	For	For
1D.	Election of Director: Kelly A. Kramer	Management	For	For
1E.	Election of Director: Kevin E. Lofton	Management	For	For
1F.	Election of Director: Harish Manwani	Management	For	For
1G.	Election of Director: Daniel P. O'Day	Management	For	For
1H.	Election of Director: Javier J. Rodriguez	Management	For	For
1I.	Election of Director: Anthony Welters	Management	For	For
2.	To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.	Management	For	For
3.	To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.	Management	For	For
4.	To approve the Gilead Sciences, Inc. 2022 Equity Incentive Plan.	Management	For	For
5.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairperson of the Board of Directors be an independent director.	Shareholder	Against	For
6.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board include one member from Gilead's non-management employees.	Shareholder	Against	For
7.	To vote on a stockholder proposal, if properly presented at the meeting, requesting a 10% threshold to call a special stockholder meeting.	Shareholder	Against	For
8.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board publish a third- party review of Gilead's lobbying activities.	Shareholder	Against	For
9.	To vote on a stockholder proposal, if properly presented at the meeting, requesting a Board report on oversight of risks related to anticompetitive practices.	Shareholder	Against	For

GLOBAL MEDICAL REIT, INC.

Security	37954A204	Meeting Type	Annual
Ticker Symbol	GMRE	Meeting Date	11-May-2022
Record Date	15-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director to serve until next annual meeting: Jeffrey M. Busch	Management	For	For
1.2	Election of Director to serve until next annual meeting: Matthew Cypher	Management	For	For
1.3	Election of Director to serve until next annual meeting: Ronald Marston	Management	For	For
1.4	Election of Director to serve until next annual meeting: Roscoe Moore, Jr.	Management	For	For
1.5	Election of Director to serve until next annual meeting: Henry E. Cole	Management	For	For
1.6	Election of Director to serve until next annual meeting: Zhang Huiqi	Management	For	For
1.7	Election of Director to serve until next annual meeting: Paula R. Crowley	Management	For	For
1.8	Election of Director to serve until next annual meeting: Lori Wittman	Management	For	For
2.	Advisory vote to approve the compensation of the Company's named executive officers as described in the accompanying Proxy Statement.	Management	For	For
3.	To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2022.	Management	For	For

GUARDANT HEALTH, INC.

Security	40131M109	Meeting Type	Annual
Ticker Symbol	GH	Meeting Date	15-Jun-2022
Record Date	18-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Class I Director: Vijaya Gadde	Management	For	For
1B.	Election of Class I Director: Myrtle Potter	Management	For	For
2.	Ratification of the appointment of Ernst & Young LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2022.	Management	For	For
3.	Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.	Management	For	For

HCA HEALTHCARE, INC.

Security	40412C101	Meeting Type	Annual
Ticker Symbol	HCA	Meeting Date	21-Apr-2022
Record Date	25-Feb-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Thomas F. Frist III	Management	For	For
1B.	Election of Director: Samuel N. Hazen	Management	For	For
1C.	Election of Director: Meg G. Crofton	Management	For	For
1D.	Election of Director: Robert J. Dennis	Management	For	For
1E.	Election of Director: Nancy-Ann DeParle	Management	For	For
1F.	Election of Director: William R. Frist	Management	For	For
1G.	Election of Director: Charles O. Holliday, Jr.	Management	For	For
1H.	Election of Director: Hugh F. Johnston	Management	For	For
1I.	Election of Director: Michael W. Michelson	Management	For	For
1J.	Election of Director: Wayne J. Riley, M.D.	Management	For	For
1K.	Election of Director: Andrea B. Smith	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2022.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For
4.	Stockholder proposal, if properly presented at the meeting, regarding political spending disclosure.	Shareholder	Against	For
5.	Stockholder proposal, if properly presented at the meeting, regarding lobbying disclosure.	Shareholder	Against	For

HEALTHCARE REALTY TRUST INCORPORATED

Security	421946104	Meeting Type	Annual
Ticker Symbol	HR	Meeting Date	10-May-2022
Record Date	16-Mar-2022

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1.	Todd J. Meredith		For	For
	2.	John V. Abbott		For	For
	3.	Nancy H. Agee		For	For
	4.	Edward H. Braman		For	For
	5.	Ajay Gupta		For	For
	6.	James J. Kilroy		For	For
	7.	Peter F. Lyle, Sr.		For	For
	8.	John Knox Singleton		For	For
	9.	Christann M. Vasquez		For	For
2.	To ratify the appointment of BDO USA, LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2022 fiscal year.		Management	For	For
3.	To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the shareholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2022 Annual Meeting of Shareholders.		Management	For	For

HEALTHCARE REALTY TRUST INCORPORATED

Security	421946104	Meeting Type	Special
Ticker Symbol	HR	Meeting Date	15-Jul-2022
Record Date	10-Jun-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	To approve the merger of HR Acquisition 2, LLC, a Maryland limited liability company and a direct, wholly- owned subsidiary of Healthcare Trust of America, Inc., a Maryland corporation (the "Company"), with and into Healthcare Realty Trust Incorporated, a Maryland Corporation ("HR"),with HR continuing as the surviving entity and a direct, wholly-owned subsidiary of the Company, pursuant to which each outstanding share of HR common stock will be exchanged for one newly- issued share of the Company's class A common stock.	Management	For	For
2.	To approve the adjournment of the special meeting, if necessary or appropriate, including to solicit additional proxies in favor of Proposal 1 if there are insufficient votes at the time of such adjournment to approve Proposal 1.	Management	For	For

HEALTHPEAK PROPERTIES, INC.

Security	42250P103	Meeting Type	Annual
Ticker Symbol	PEAK	Meeting Date	28-Apr-2022
Record Date	01-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Brian G. Cartwright	Management	For	For
1B.	Election of Director: Christine N. Garvey	Management	For	For
1C.	Election of Director: R. Kent Griffin, Jr.	Management	For	For
1D.	Election of Director: David B. Henry	Management	For	For
1E.	Election of Director: Thomas M. Herzog	Management	For	For
1F.	Election of Director: Lydia H. Kennard	Management	For	For
1G.	Election of Director: Sara G. Lewis	Management	For	For
1H.	Election of Director: Katherine M. Sandstrom	Management	For	For
2.	Approval of 2021 executive compensation on an advisory basis.	Management	For	For
3.	Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2022.	Management	For	For

HORIZON THERAPEUTICS PLC

Security	G46188101	Meeting Type	Annual
Ticker Symbol	HZNP	Meeting Date	28-Apr-2022
Record Date	24-Feb-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Class II Director: Michael Grey	Management	For	For
1B.	Election of Class II Director: Jeff Himawan, Ph.D.	Management	For	For
1C.	Election of Class II Director: Susan Mahony, Ph.D.	Management	For	For
2.	Approval of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022 and authorization of the Audit Committee to determine the auditors' remuneration.	Management	For	For
3.	Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy Statement.	Management	For	For
4.	Authorization for us and/or any of our subsidiaries to make market purchases or overseas market purchases of our ordinary shares.	Management	For	For
5.	Approval of the Amended and Restated 2020 Equity Incentive Plan.	Management	For	For

HOYA CORPORATION

Security	J22848105	Meeting Type	Annual General Meeting
Ticker Symbol	7741 JP	Meeting Date	28-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
	Please reference meeting materials.	Non-Voting
1.1	Appoint a Director Urano, Mitsudo	Management	For	For
1.2	Appoint a Director Kaihori, Shuzo	Management	For	For
1.3	Appoint a Director Yoshihara, Hiroaki	Management	For	For
1.4	Appoint a Director Abe, Yasuyuki	Management	For	For
1.5	Appoint a Director Hasegawa, Takayo	Management	For	For
1.6	Appoint a Director Nishimura, Mika	Management	For	For
1.7	Appoint a Director Ikeda, Eiichiro	Management	For	For
1.8	Appoint a Director Hirooka, Ryo	Management	For	For
2.	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations, Approve Minor Revisions	Management	For	For

HUMANA, INC.

Security	444859102	Meeting Type	Annual
Ticker Symbol	HUM	Meeting Date	21-Apr-2022
Record Date	28-Feb-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A)	Election of Director: Raquel C. Bono, M.D.	Management	For	For
1B)	Election of Director: Bruce D. Broussard	Management	For	For
1C)	Election of Director: Frank A. D'Amelio	Management	For	For
1D)	Election of Director: David T. Feinberg, M.D.	Management	For	For
1E)	Election of Director: Wayne A. I. Frederick, M.D.	Management	For	For
1F)	Election of Director: John W. Garratt	Management	For	For
1G)	Election of Director: Kurt J. Hilzinger	Management	For	For
1H)	Election of Director: David A. Jones, Jr.	Management	For	For
1I)	Election of Director: Karen W. Katz	Management	For	For
1J)	Election of Director: Marcy S. Klevorn	Management	For	For
1K)	Election of Director: William J. McDonald	Management	For	For
1L)	Election of Director: Jorge S. Mesquita	Management	For	For
1M)	Election of Director: James J. O'Brien	Management	For	For
2)	The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.	Management	For	For
3)	Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2022 proxy statement.	Management	For	For

ICON PLC

Security	G4705A100	Meeting Type	Annual
Ticker Symbol	ICLR	Meeting Date	20-Jul-2021
Record Date	10-Jun-2021

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Mr. Ciaran Murray	Management	For	For
1.2	Election of Director: Ms. Joan Garahy	Management	For	For
1.3	Election of Director: Mr. Eugene McCague	Management	For	For
2.1	Subject to and conditional upon the completion of the Acquisition to elect: Mr. Colin Shannon	Management	For	For
2.2	Subject to and conditional upon the completion of the Acquisition to elect: Dr. Linda Grais	Management	For	For
3.	To review the Company's affairs and consider the Accounts and Reports.	Management	For	For
4.	To authorise the fixing of the Auditors' Remuneration.	Management	For	For
5.	To authorise the Company to allot shares.	Management	For	For
6.	To disapply the statutory pre-emption rights.	Management	For	For
7.	To disapply the statutory pre-emption rights for funding capital investment or acquisitions.	Management	For	For
8.	To authorise the Company to make market purchases of shares.	Management	For	For
9.	To authorise the price range at which the Company can reissue shares that it holds as treasury shares.	Management	For	For

IDEXX LABORATORIES, INC.

Security	45168D104	Meeting Type	Annual
Ticker Symbol	IDXX	Meeting Date	11-May-2022
Record Date	14-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director (Proposal One): Jonathan W. Ayers	Management	For	For
1B.	Election of Director (Proposal One): Stuart M. Essig, PhD	Management	For	For
1C.	Election of Director (Proposal One): Jonathan J. Mazelsky	Management	For	For
1D.	Election of Director (Proposal One): M. Anne Szostak	Management	For	For
2.	Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two).	Management	For	For
3.	Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).	Management	For	For

ILLUMINA, INC.

Security	452327109	Meeting Type	Annual
Ticker Symbol	ILMN	Meeting Date	26-May-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Frances Arnold, Ph.D.	Management	For	For
1B.	Election of Director: Francis A. deSouza	Management	For	For
1C.	Election of Director: Caroline D. Dorsa	Management	For	For
1D.	Election of Director: Robert S. Epstein, M.D.	Management	For	For
1E.	Election of Director: Scott Gottlieb, M.D.	Management	For	For
1F.	Election of Director: Gary S. Guthart, Ph.D.	Management	For	For
1G.	Election of Director: Philip W. Schiller	Management	For	For
1H.	Election of Director: Susan E. Siegel	Management	For	For
1I.	Election of Director: John W. Thompson	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 1, 2023.	Management	For	For
3.	To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement.	Management	For	For
4.	To approve, on an advisory basis, a stockholder proposal regarding the right of stockholders to call special meetings.	Shareholder	Against	For
5.	To approve an amendment to our Amended and Restated Certificate of Incorporation to permit stockholders to call special meetings.	Management	For	For

INTUITIVE SURGICAL, INC.

Security	46120E602	Meeting Type	Special
Ticker Symbol	ISRG	Meeting Date	20-Sep-2021
Record Date	18-Aug-2021

Item	Proposal	Proposed by	Vote	For/Against Management
1.	TO APPROVE THE COMPANY'S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FOR THE PURPOSE OF EFFECTING A THREE-FOR-ONE STOCK SPLIT.	Management	For	For

INTUITIVE SURGICAL, INC.

Security	46120E602	Meeting Type	Annual
Ticker Symbol	ISRG	Meeting Date	28-Apr-2022
Record Date	01-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Craig H. Barratt, Ph.D.	Management	For	For
1B.	Election of Director: Joseph C. Beery	Management	For	For
1C.	Election of Director: Gary S. Guthart, Ph.D.	Management	For	For
1D.	Election of Director: Amal M. Johnson	Management	For	For
1E.	Election of Director: Don R. Kania, Ph.D.	Management	For	For
1F.	Election of Director: Amy L. Ladd, M.D.	Management	For	For
1G.	Election of Director: Keith R. Leonard, Jr.	Management	For	For
1H.	Election of Director: Alan J. Levy, Ph.D.	Management	For	For
1I.	Election of Director: Jami Dover Nachtsheim	Management	For	For
1J.	Election of Director: Monica P. Reed, M.D.	Management	For	For
1K.	Election of Director: Mark J. Rubash	Management	For	For
2.	To approve, by advisory vote, the compensation of the Company's Named Executive Officers.	Management	For	For
3.	The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.	Management	For	For
4.	To approve the Company's Amended and Restated 2010 Incentive Award Plan.	Management	For	For

IQVIA HOLDINGS INC.

Security	46266C105	Meeting Type	Annual
Ticker Symbol	IQV	Meeting Date	12-Apr-2022
Record Date	15-Feb-2022

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1.	John P. Connaughton		For	For
	2.	John G. Danhakl		For	For
	3.	James A. Fasano		For	For
	4.	Leslie Wims Morris		For	For
2.	Amendment to Certificate of Incorporation to declassify the Board of Directors over time and provide for the annual election of all directors.		Management	For	For
3.	Advisory (non-binding) vote to approve executive compensation (say-on-pay).		Management	For	For
4.	If properly presented, a shareholder proposal regarding majority voting in uncontested director elections.		Management	Against	For
5.	The ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA Holdings Inc.'s independent registered public accounting firm for the year ending December 31, 2022.		Management	For	For

JOHNSON & JOHNSON

Security	478160104	Meeting Type	Annual
Ticker Symbol	JNJ	Meeting Date	28-Apr-2022
Record Date	01-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Darius Adamczyk	Management	For	For
1B.	Election of Director: Mary C. Beckerle	Management	For	For
1C.	Election of Director: D. Scott Davis	Management	For	For
1D.	Election of Director: Ian E. L. Davis	Management	For	For
1E.	Election of Director: Jennifer A. Doudna	Management	For	For
1F.	Election of Director: Joaquin Duato	Management	For	For
1G.	Election of Director: Alex Gorsky	Management	For	For
1H.	Election of Director: Marillyn A. Hewson	Management	For	For
1I.	Election of Director: Hubert Joly	Management	For	For
1J.	Election of Director: Mark B. McClellan	Management	For	For
1K.	Election of Director: Anne M. Mulcahy	Management	For	For
1L.	Election of Director: A. Eugene Washington	Management	For	For
1M.	Election of Director: Mark A. Weinberger	Management	For	For
1N.	Election of Director: Nadja Y. West	Management	For	For
2.	Advisory Vote to Approve Named Executive Officer Compensation.	Management	For	For
3.	Approval of the Company's 2022 Long-Term Incentive Plan.	Management	For	For
4.	Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2022.	Management	For	For
5.	Proposal Withdrawn (Federal Securities Laws Mandatory Arbitration Bylaw).	Shareholder	Against
6.	Civil Rights, Equity, Diversity & Inclusion Audit Proposal.	Shareholder	Against	For
7.	Third Party Racial Justice Audit.	Shareholder	Against	For
8.	Report on Government Financial Support and Access to COVID-19 Vaccines and Therapeutics.	Shareholder	Against	For
9.	Report on Public Health Costs of Protecting Vaccine Technology.	Shareholder	Against	For
10.	Discontinue Global Sales of Baby Powder Containing Talc.	Shareholder	Against	For
11.	Request for Charitable Donations Disclosure.	Shareholder	Against	For
12.	Third Party Review and Report on Lobbying Activities Alignment with Position on Universal Health Coverage.	Shareholder	Against	For
13.	Adopt Policy to Include Legal and Compliance Costs in Incentive Compensation Metrics.	Shareholder	Against	For
14.	CEO Compensation to Weigh Workforce Pay and Ownership.	Shareholder	Against	For

KONINKLIJKE PHILIPS ELECTRONICS N.V.

Security	500472303	Meeting Type	Annual
Ticker Symbol	PHG	Meeting Date	10-May-2022
Record Date	12-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
2B.	Annual Report 2021: Proposal to adopt the financial statements	Management	For
2C.	Annual Report 2021: Proposal to adopt dividend	Management	For
2D.	Annual Report 2021: Advisory vote on the Remuneration Report 2021	Management	For
2E.	Annual Report 2021: Proposal to discharge the members of the Board of Management	Management	For
2F.	Annual Report 2021: Proposal to discharge the members of the Supervisory Board	Management	For
3A.	Composition of the Supervisory Board: Proposal to re- appoint Mr P.A.M. Stoffels as member of the Supervisory Board	Management	For
3B.	Composition of the Supervisory Board: Proposal to re- appoint Mr A. Marc Harrison as member of the Supervisory Board	Management	For
3C.	Composition of the Supervisory Board: Proposal to appoint Mrs H.W.P.M.A. Verhagen as member of the Supervisory Board	Management	For
3D.	Composition of the Supervisory Board: Proposal to appoint Mr S.J. Poonen as member of the Supervisory Board	Management	For
4.	Proposal to re-appoint Ernst & Young Accountants LLP as the company's auditor	Management	For
5A.	Proposal to authorize the Board of Management to: issue shares or grant rights to acquire shares	Management	For
5B.	Proposal to authorize the Board of Management to: restrict or exclude pre-emption rights	Management	For
6.	Proposal to authorize the Board of Management to acquire shares in the company	Management	For
7.	Proposal to cancel shares	Management	For

LABORATORY CORP. OF AMERICA HOLDINGS

Security	50540R409	Meeting Type	Annual
Ticker Symbol	LH	Meeting Date	11-May-2022
Record Date	16-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Kerrii B. Anderson	Management	For	For
1B.	Election of Director: Jean-Luc Bélingard	Management	For	For
1C.	Election of Director: Jeffrey A. Davis	Management	For	For
1D.	Election of Director: D. Gary Gilliland, M.D., Ph.D.	Management	For	For
1E.	Election of Director: Garheng Kong, M.D., Ph.D.	Management	For	For
1F.	Election of Director: Peter M. Neupert	Management	For	For
1G.	Election of Director: Richelle P. Parham	Management	For	For
1H.	Election of Director: Adam H. Schechter	Management	For	For
1I.	Election of Director: Kathryn E. Wengel	Management	For	For
1J.	Election of Director: R. Sanders Williams, M.D.	Management	For	For
2.	To approve, by non-binding vote, executive compensation.	Management	For	For
3.	Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2022.	Management	For	For
4.	Shareholder proposal seeking an amendment to our governing documents relating to procedural requirements in connection with shareholders' rights to call a special meeting.	Shareholder	Against	For

LONZA GROUP AG

Security	H50524133	Meeting Type	Annual General Meeting
Ticker Symbol	LONN SW	Meeting Date	05-May-2022
Record Date	21-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	ANNUAL REPORT, CONSOLIDATED FINANCIAL STATEMENTS AND FINANCIAL STATEMENTS OF LONZA	Management	For	For
2.	CONSULTATIVE VOTE ON THE REMUNERATION REPORT	Management	For	For
3.	DISCHARGE OF THE MEMBERS OF THE BOARD OF DIRECTORS AND THE EXECUTIVE COMMITTEE	Management	For	For
4.	APPROPRIATION OF AVAILABLE EARNINGS / RESERVES FROM CAPITAL CONTRIBUTION	Management	For	For
5.1.A	RE-ELECTION TO THE BOARD OF DIRECTORS: ALBERT M. BAEHNY	Management	For	For
5.1.B	RE-ELECTION TO THE BOARD OF DIRECTORS: ANGELICA KOHLMANN	Management	For	For
5.1.C	RE-ELECTION TO THE BOARD OF DIRECTORS: CHRISTOPH MAEDER	Management	For	For
5.1.D	RE-ELECTION TO THE BOARD OF DIRECTORS: BARBARA RICHMOND	Management	For	For
5.1.E	RE-ELECTION TO THE BOARD OF DIRECTORS: JUERGEN STEINEMANN	Management	For	For
5.1.F	RE-ELECTION TO THE BOARD OF DIRECTORS: OLIVIER VERSCHEURE	Management	For	For
5.2.A	ELECTION TO THE BOARD OF DIRECTORS: MARION HELMES	Management	For	For
5.2.B	ELECTION TO THE BOARD OF DIRECTORS: ROGER NITSCH	Management	For	For
5.3	RE-ELECTION OF ALBERT M. BAEHNY AS CHAIRMAN OF THE BOARD OF DIRECTORS	Management	For	For
5.4.A	RE-ELECTION TO THE NOMINATION AND COMPENSATION COMMITTEE: ANGELICA KOHLMANN	Management	For	For
5.4.B	RE-ELECTION TO THE NOMINATION AND COMPENSATION COMMITTEE: CHRISTOPH MAEDER	Management	For	For
5.4.C	RE-ELECTION TO THE NOMINATION AND COMPENSATION COMMITTEE: JUERGEN STEINEMANN	Management	For	For
6.	RE-ELECTION OF KPMG LTD, ZURICH AS AUDITORS	Management	For	For
7.	RE-ELECTION OF THOMANNFISCHER, BASEL AS INDEPENDENT PROXY	Management	For	For
8.	COMPENSATION OF THE BOARD OF DIRECTORS	Management	For	For
9.	COMPENSATION OF THE EXECUTIVE COMMITTEE: MAXIMUM AGGREGATE AMOUNT OF FIXED COMPENSATION OF THE EXECUTIVE COMMITTEE	Management	For	For
9.	COMPENSATION OF THE EXECUTIVE COMMITTEE: AGGREGATE AMOUNT OF VARIABLE SHORT-TERM COMPENSATION OF THE EXECUTIVE COMMITTEE	Management	For	For
9.	COMPENSATION OF THE EXECUTIVE COMMITTEE: MAXIMUM AGGREGATE AMOUNT OF VARIABLE LONG-TERM COMPENSATION OF THE EXECUTIVE COMMITTEE	Management	For	For
10.	IN THE EVENT OF ANY YET UNKNOWN NEW OR MODIFIED PROPOSAL BY A SHAREHOLDER DURING THE ANNUAL GENERAL MEETING, I INSTRUCT THE INDEPENDENT REPRESENTATIVE TO VOTE AS FOLLOWS (YES = VOTE IN FAVOR OF ANY SUCH YET UNKONWN PROPOSAL; NO = VOTE AGAINST ANY SUCH YET UNKNOWN PROPOSAL; ABSTAIN)	Shareholder	Against	For

LTC PROPERTIES, INC.

Security	502175102	Meeting Type	Annual
Ticker Symbol	LTC	Meeting Date	25-May-2022
Record Date	11-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director to hold office until the 2023 Annual Meeting: Cornelia Cheng	Management	For	For
1B.	Election of Director to hold office until the 2023 Annual Meeting: Boyd W. Hendrickson	Management	For	For
1C.	Election of Director to hold office until the 2023 Annual Meeting: James J. Pieczynski	Management	For	For
1D.	Election of Director to hold office until the 2023 Annual Meeting: Devra G. Shapiro	Management	For	For
1E.	Election of Director to hold office until the 2023 Annual Meeting: Wendy L. Simpson	Management	For	For
1F.	Election of Director to hold office until the 2023 Annual Meeting: Timothy J. Triche	Management	For	For
2.	Ratification of independent registered public accounting firm.	Management	For	For
3.	Advisory vote to approve named executive officer compensation.	Management	For	For

M3, Inc.

Security	J4697J108	Meeting Type	Annual General Meeting
Ticker Symbol	2413 JP	Meeting Date	28-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations, Establish the Articles Related to Shareholders Meeting Held without Specifying a Venue	Management	For	For
2.1	Appoint a Director who is not Audit and Supervisory Committee Member Tanimura, Itaru	Management	For	For
2.2	Appoint a Director who is not Audit and Supervisory Committee Member Tomaru, Akihiko	Management	For	For
2.3	Appoint a Director who is not Audit and Supervisory Committee Member Tsuchiya, Eiji	Management	For	For
2.4	Appoint a Director who is not Audit and Supervisory Committee Member Izumiya, Kazuyuki	Management	For	For
2.5	Appoint a Director who is not Audit and Supervisory Committee Member Nakamura, Rie	Management	For	For
2.6	Appoint a Director who is not Audit and Supervisory Committee Member Yoshida, Kenichiro	Management	For	For
3.1	Appoint a Director who is Audit and Supervisory Committee Member Yamazaki, Mayuka	Management	For	For
3.2	Appoint a Director who is Audit and Supervisory Committee Member Ebata, Takako	Management	For	For
3.3	Appoint a Director who is Audit and Supervisory Committee Member Toyama, Ryoko	Management	For	For

MALLINCKRODT PLC

Security	G5785G107	Meeting Type	Annual
Ticker Symbol	MNKKQ	Meeting Date	13-Aug-2021
Record Date	14-Jun-2021

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: David R. Carlucci	Management	For	For
1B.	Election of Director: J. Martin Carroll	Management	For	For
1C.	Election of Director: Paul R. Carter	Management	For	For
1D.	Election of Director: David Y. Norton	Management	For	For
1E.	Election of Director: Carlos V. Paya, M.D.	Management	For	For
1F.	Election of Director: JoAnn A. Reed	Management	For	For
1G.	Election of Director: Angus C. Russell	Management	For	For
1H.	Election of Director: Mark C. Trudeau	Management	For	For
1I.	Election of Director: Anne C. Whitaker	Management	For	For
1J.	Election of Director: Kneeland C. Youngblood, M.D.	Management	For	For
2.	Approve, in a non-binding vote, the re-appointment of the independent auditors and authorize, in a binding vote, the Audit Committee to set the auditors' remuneration.	Management	For	For
3.	Advisory vote to approve the Company's executive compensation.	Management	For	For

MCKESSON CORPORATION

Security	58155Q103	Meeting Type	Annual
Ticker Symbol	MCK	Meeting Date	23-Jul-2021
Record Date	28-May-2021

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director for a one-year term: Dominic J. Caruso	Management	For	For
1B.	Election of Director for a one-year term: Donald R. Knauss	Management	For	For
1C.	Election of Director for a one-year term: Bradley E. Lerman	Management	For	For
1D.	Election of Director for a one-year term: Linda P. Mantia	Management	For	For
1E.	Election of Director for a one-year term: Maria Martinez	Management	For	For
1F.	Election of Director for a one-year term: Edward A. Mueller	Management	For	For
1G.	Election of Director for a one-year term: Susan R. Salka	Management	For	For
1H.	Election of Director for a one-year term: Brian S. Tyler	Management	For	For
1I.	Election of Director for a one-year term: Kenneth E. Washington	Management	For	For
2.	Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending March 31, 2022.	Management	For	For
3.	Advisory vote on executive compensation.	Management	For	For
4.	Shareholder proposal on action by written consent of shareholders.	Shareholder	Against	For

MEDICAL PROPERTIES TRUST, INC.

Security	58463J304	Meeting Type	Annual
Ticker Symbol	MPW	Meeting Date	26-May-2022
Record Date	29-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Edward K. Aldag, Jr.	Management	For	For
1.2	Election of Director: G. Steven Dawson	Management	For	For
1.3	Election of Director: R. Steven Hamner	Management	For	For
1.4	Election of Director: Caterina A. Mozingo	Management	For	For
1.5	Election of Director: Emily W. Murphy	Management	For	For
1.6	Election of Director: Elizabeth N. Pitman	Management	For	For
1.7	Election of Director: D. Paul Sparks, Jr.	Management	For	For
1.8	Election of Director: Michael G. Stewart	Management	For	For
1.9	Election of Director: C. Reynolds Thompson, III	Management	For	For
2.	To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2022.	Management	For	For
3.	To approve the compensation of the Company's executive officers, on a non-binding basis.	Management	For	For
4.	To approve the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Investment Plan.	Management	For	For

MEDTRONIC PLC

Security	G5960L103	Meeting Type	Annual
Ticker Symbol	MDT	Meeting Date	09-Dec-2021
Record Date	14-Oct-2021

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director until the 2022 Annual General Meeting: Richard H. Anderson	Management	For	For
1B.	Election of Director until the 2022 Annual General Meeting: Craig Arnold	Management	For	For
1C.	Election of Director until the 2022 Annual General Meeting: Scott C. Donnelly	Management	For	For
1D.	Election of Director until the 2022 Annual General Meeting: Andrea J. Goldsmith, Ph.D.	Management	For	For
1E.	Election of Director until the 2022 Annual General Meeting: Randall J. Hogan, III	Management	For	For
1F.	Election of Director until the 2022 Annual General Meeting: Kevin E. Lofton	Management	For	For
1G.	Election of Director until the 2022 Annual General Meeting: Geoffrey S. Martha	Management	For	For
1H.	Election of Director until the 2022 Annual General Meeting: Elizabeth G. Nabel, M.D.	Management	For	For
1I.	Election of Director until the 2022 Annual General Meeting: Denise M. O'Leary	Management	For	For
1J.	Election of Director until the 2022 Annual General Meeting: Kendall J. Powell	Management	For	For
2.	Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2022 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration.	Management	For	For
3.	Approving, on an advisory basis, the Company's executive compensation.	Management	For	For
4.	Approving, on an advisory basis, the frequency of Say- on-Pay votes.	Management	1 Year	For
5.	Approving the new 2021 Medtronic plc Long Term Incentive Plan.	Management	For	For
6.	Renewing the Board of Directors' authority to issue shares under Irish law.	Management	For	For
7.	Renewing the Board of Directors' authority to opt out of pre- emption rights under Irish law.	Management	For	For
8.	Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.	Management	For	For

MERCK & CO., INC.

Security	58933Y105	Meeting Type	Annual
Ticker Symbol	MRK	Meeting Date	24-May-2022
Record Date	25-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Douglas M. Baker, Jr.	Management	For	For
1B.	Election of Director: Mary Ellen Coe	Management	For	For
1C.	Election of Director: Pamela J. Craig	Management	For	For
1D.	Election of Director: Robert M. Davis	Management	For	For
1E.	Election of Director: Kenneth C. Frazier	Management	For	For
1F.	Election of Director: Thomas H. Glocer	Management	For	For
1G.	Election of Director: Risa J. Lavizzo-Mourey, M.D.	Management	For	For
1H.	Election of Director: Stephen L. Mayo, Ph.D.	Management	For	For
1I.	Election of Director: Paul B. Rothman, M.D.	Management	For	For
1J.	Election of Director: Patricia F. Russo	Management	For	For
1K.	Election of Director: Christine E. Seidman, M.D.	Management	For	For
1L.	Election of Director: Inge G. Thulin	Management	For	For
1M.	Election of Director: Kathy J. Warden	Management	For	For
1N.	Election of Director: Peter C. Wendell	Management	For	For
2.	Non-binding advisory vote to approve the compensation of our named executive officers.	Management	For	For
3.	Ratification of the appointment of the Company's independent registered public accounting firm for 2022.	Management	For	For
4.	Shareholder proposal regarding an independent board chairman.	Shareholder	For	Against
5.	Shareholder proposal regarding access to COVID-19 products.	Shareholder	Against	For
6.	Shareholder proposal regarding lobbying expenditure disclosure.	Shareholder	Against	For

MODERNA, INC.

Security	60770K107	Meeting Type	Annual
Ticker Symbol	MRNA	Meeting Date	28-Apr-2022
Record Date	01-Mar-2022

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1.	Noubar Afeyan, Ph.D.		For	For
	2.	Stéphane Bancel		For	For
	3.	François Nader, M.D.		For	For
2.	To approve, on a non-binding, advisory basis, the compensation of our named executive officers.		Management	For	For
3.	To ratify the appointment of Ernst & Young LLP as our registered independent public accounting firm for the year ending December 31, 2022.		Management	For	For
4.	To vote on a shareholder proposal relating to the feasibility of transferring intellectual property.		Shareholder	For	Against

MOLINA HEALTHCARE, INC.

Security	60855R100	Meeting Type	Annual
Ticker Symbol	MOH	Meeting Date	04-May-2022
Record Date	07-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director to hold office until the 2023 Annual Meeting: Barbara L. Brasier	Management	For	For
1B.	Election of Director to hold office until the 2023 Annual Meeting: Daniel Cooperman	Management	For	For
1C.	Election of Director to hold office until the 2023 Annual Meeting: Stephen H. Lockhart	Management	For	For
1D.	Election of Director to hold office until the 2023 Annual Meeting: Steven J. Orlando	Management	For	For
1E.	Election of Director to hold office until the 2023 Annual Meeting: Ronna E. Romney	Management	For	For
1F.	Election of Director to hold office until the 2023 Annual Meeting: Richard M. Schapiro	Management	For	For
1G.	Election of Director to hold office until the 2023 Annual Meeting: Dale B. Wolf	Management	For	For
1H.	Election of Director to hold office until the 2023 Annual Meeting: Richard C. Zoretic	Management	For	For
1I.	Election of Director to hold office until the 2023 Annual Meeting: Joseph M. Zubretsky	Management	For	For
2.	To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.	Management	For	For
3.	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2022.	Management	For	For

MORPHOSYS AG

Security	617760202	Meeting Type	Annual
Ticker Symbol	MOR	Meeting Date	18-May-2022
Record Date	08-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
2.	Resolution on the discharge of Management Board members for the 2021 financial year	Management	For	For
3.	Resolution on the discharge of Supervisory Board members for the 2021 financial year	Management	For	For
4.	Resolution on the appointment of the auditor for the 2022 financial year	Management	For	For
5.	Resolution on the election of a member of the Supervisory Board: Mr Andrew Cheng	Management	For	For
6.	Resolution on the reduction of the Conditional Capital 2016-III, on the reduction of the Conditional Capital 2020- I and on the reduction of the Authorized Capital 2019-I; Amendments to the Articles of Association	Management	For	For
7.	Resolution on the creation of a new Authorized Capital 2022-I under exclusion of subscription rights for the purpose of servicing "Restricted Stock Units" to be issued to senior managers and employees (including directors and officers) of U.S. subsidiaries of the Company under a "Restricted Stock Unit Program"; Amendment to the Articles of Association	Management	For	For
8.	Resolution on the approval of the remuneration system for the members of the Management Board	Management	For	For
9.	Resolution on the approval of the Remuneration Report for the financial year 2021	Management	For	For

NATIONAL HEALTH INVESTORS, INC.

Security	63633D104	Meeting Type	Annual
Ticker Symbol	NHI	Meeting Date	06-May-2022
Record Date	11-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: James R. Jobe	Management	For	For
1B.	Election of Director: Robert G. Adams	Management	For	For
2.	Approve the advisory resolution approving the compensation of the named executive officers as disclosed in the accompanying Proxy Statement.	Management	For	For
3.	Ratify the audit committee's selection of BDO USA, LLP as independent registered public accounting firm for the year ending December 31, 2022.	Management	For	For

NEW SENIOR INVESTMENT GROUP, INC.

Security	648691103	Meeting Type	Special
Ticker Symbol	SNR	Meeting Date	14-Sep-2021
Record Date	06-Aug-2021

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Adopt the Agreement and Plan of Merger, dated as of June 28, 2021 (as amended or otherwise modified from time to time, the "Merger Agreement"), by and among New Senior Investment Group Inc., a Delaware corporation ("New Senior"), Ventas, Inc., a Delaware corporation ("Ventas"), and Cadence Merger Sub LLC, a Delaware limited liability company and a subsidiary of Ventas, Inc. ("Merger Sub"), and thereby approve the merger of Merger Sub with and into New Senior, with New Senior continuing as the surviving corporation and a subsidiary of Ventas.	Management	For	For
2.	Approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the named executive officers of New Senior in connection with transactions contemplated by the Merger Agreement.	Management	For	For
3.	Approve the adjournment of the special meeting of the New Senior stockholders (the "Special Meeting") from time to time, if necessary or appropriate, (i) to solicit additional proxies in favor of the proposal to adopt the Merger Agreement if there are insufficient votes at the time of such adjournment to approve such proposal or (ii) if required to enable New Senior or Ventas to comply with the requirement in the Merger Agreement to provide notice to the other party 10 business days prior to the Special Meeting	Management	For	For

NOVARTIS AG

Security	66987V109	Meeting Type	Annual
Ticker Symbol	NVS	Meeting Date	04-Mar-2022
Record Date	25-Jan-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the Operating and Financial Review of Novartis AG, the Financial Statements of Novartis AG and the Group Consolidated Financial Statements for the 2021 Financial Year.	Management	For	For
2.	Discharge from Liability of the Members of the Board of Directors and the Executive Committee.	Management	For	For
3.	Appropriation of Available Earnings of Novartis AG as per Balance Sheet and Declaration of Dividend for 2021.	Management	For	For
4.	Reduction of Share Capital.	Management	For	For
5.	Further Share Repurchases.	Management	For	For
6A.	Binding Vote on the Maximum Aggregate Amount of Compensation for the Board of Directors from the 2022 Annual General Meeting to the 2023 Annual General Meeting.	Management	For	For
6B.	Binding Vote on the Maximum Aggregate Amount of Compensation for the Executive Committee for the Financial Year 2023.	Management	For	For
6C.	Advisory Vote on the 2021 Compensation Report.	Management	For	For
7A.	Re-election of Joerg Reinhardt as Member and Board Chair	Management	For	For
7B.	Re-election of Nancy C. Andrews	Management	For	For
7C.	Re-election of Ton Buechner	Management	For	For
7D.	Re-election of Patrice Bula	Management	For	For
7E.	Re-election of Elizabeth Doherty	Management	For	For
7F.	Re-election of Bridgette Heller	Management	For	For
7G.	Re-election of Frans van Houten	Management	For	For
7H.	Re-election of Simon Moroney	Management	For	For
7I.	Re-election of Andreas von Planta	Management	For	For
7J.	Re-election of Charles L. Sawyers	Management	For	For
7K.	Re-election of William T. Winters	Management	For	For
7L.	Election of Ana de Pro Gonzalo	Management	For	For
7M.	Election of Daniel Hochstrasser	Management	For	For
8A.	Re-election of Patrice Bula as Compensation Committee member	Management	For	For
8B.	Re-election of Bridgette Heller as Compensation Committee member	Management	For	For
8C.	Re-election of Simon Moroney as Compensation Committee member	Management	For	For
8D.	Re-election of William T. Winters as Compensation Committee member	Management	For	For
9.	Election of the Statutory Auditor.	Management	For	For
10.	Re-election of the Independent Proxy.	Management	For	For
11.	General instructions in case of alternative motions under the agenda items published in the Notice of Annual General Meeting, and/or of motions relating to additional agenda items according to Article 700 paragraph 3 of the Swiss Code of Obligations.	Management	For	For

OCULIS SA

Security	N/A	Meeting Type	Written Consent
Ticker Symbol	N/A	Meeting Date	27-Apr-2022
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the Financial Statements 2021.	Management	For	For
2.	Appropriation of Balance Sheet Results 2021.	Management	For	For
3.	Discharge of the Members of the Board and Management.	Management	For	For
4.	Re-Election of the Board of Directors:
4.1	Mr. Anthony (Tony) Rosenberg	Management	For	For
4.2	Dr. Riad Sherif	Management	For	For
4.3	Mr. Àrni Audunn Blöndal	Management	For	For
4.4	Mr. Lionel Carnot	Management	For	For
4.5	Mr. Bartosz Dzikowski	Management	For	For
4.6	Dr. Xin (Sylvia) He	Management	For	For
4.7	Dr. Robert Lorne Hopfner	Management	For	For
4.8	Ms. Yi Fei (Vanessa) Huang	Management	For	For
4.9	Dr. Henry Skinner	Management	For	For
5.	Re-Election of the Auditors PricewaterhouseCoopers SA.	Management	For	For

OCULIS SA

Security	N/A	Meeting Type	Extraordinary General Meeting
Ticker Symbol	N/A	Meeting Date	30-Nov-2021
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Ordinary share capital increase	Management	For	For
2.	Conditional capital share increase	Management	For	For

OLYMPUS CORPORATION

Security	J61240107	Meeting Type	Annual General Meeting
Ticker Symbol	7733 JP	Meeting Date	24-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations	Management	For	For
2.1	Appoint a Director Takeuchi, Yasuo	Management	For	For
2.2	Appoint a Director Fujita, Sumitaka	Management	For	For
2.3	Appoint a Director Iwamura, Tetsuo	Management	For	For
2.4	Appoint a Director Masuda, Yasumasa	Management	For	For
2.5	Appoint a Director David Robert Hale	Management	For	For
2.6	Appoint a Director Jimmy C. Beasley	Management	For	For
2.7	Appoint a Director Ichikawa, Sachiko	Management	For	For
2.8	Appoint a Director Shingai, Yasushi	Management	For	For
2.9	Appoint a Director Kan, Kohei	Management	For	For
2.10	Appoint a Director Gary John Pruden	Management	For	For
2.11	Appoint a Director Stefan Kaufmann	Management	For	For
2.12	Appoint a Director Koga, Nobuyuki	Management	For	For

OMEGA HEALTHCARE INVESTORS, INC.

Security	681936100	Meeting Type	Annual
Ticker Symbol	OHI	Meeting Date	03-Jun-2022
Record Date	06-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Kapila K. Anand	Management	For	For
1B.	Election of Director: Craig R. Callen	Management	For	For
1C.	Election of Director: Dr. Lisa C. Egbuonu-Davis	Management	For	For
1D.	Election of Director: Barbara B. Hill	Management	For	For
1E.	Election of Director: Kevin J. Jacobs	Management	For	For
1F.	Election of Director: C. Taylor Pickett	Management	For	For
1G.	Election of Director: Stephen D. Plavin	Management	For	For
1H.	Election of Director: Burke W. Whitman	Management	For	For
2.	Ratification of Independent Auditors Ernst & Young LLP for fiscal year 2022.	Management	For	For
3.	Approval, on an Advisory Basis, of Executive Compensation.	Management	For	For

ONO PHARMACEUTICAL CO.,LTD.

Security	J61546115	Meeting Type	Annual General Meeting
Ticker Symbol	4528 JP	Meeting Date	23-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approve Appropriation of Surplus	Management	For	For
2.	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations, Approve Minor Revisions	Management	For	For
3.1	Appoint a Director Sagara, Gyo	Management	For	For
3.2	Appoint a Director Tsujinaka, Toshihiro	Management	For	For
3.3	Appoint a Director Takino, Toichi	Management	For	For
3.4	Appoint a Director Ono, Isao	Management	For	For
3.5	Appoint a Director Idemitsu, Kiyoaki	Management	For	For
3.6	Appoint a Director Nomura, Masao	Management	For	For
3.7	Appoint a Director Okuno, Akiko	Management	For	For
3.8	Appoint a Director Nagae, Shusaku	Management	For	For
4.	Approve Details of the Compensation to be received by Directors	Management	For	For
5.	Approve Details of the Restricted-Stock Compensation to be received by Directors	Management	For	For

OTSUKA HOLDINGS CO.,LTD.

Security	J63117105	Meeting Type	Annual General Meeting
Ticker Symbol	4578 JP	Meeting Date	30-Mar-2022
Record Date	31-Dec-2021

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations, Establish the Articles Related to Shareholders Meeting held without specifying a venue	Management	For	For
2.1	Appoint a Director Otsuka, Ichiro	Management	For	For
2.2	Appoint a Director Higuchi, Tatsuo	Management	For	For
2.3	Appoint a Director Matsuo, Yoshiro	Management	For	For
2.4	Appoint a Director Makino, Yuko	Management	For	For
2.5	Appoint a Director Takagi, Shuichi	Management	For	For
2.6	Appoint a Director Tobe, Sadanobu	Management	For	For
2.7	Appoint a Director Kobayashi, Masayuki	Management	For	For
2.8	Appoint a Director Tojo, Noriko	Management	For	For
2.9	Appoint a Director Inoue, Makoto	Management	For	For
2.10	Appoint a Director Matsutani, Yukio	Management	For	For
2.11	Appoint a Director Sekiguchi, Ko	Management	For	For
2.12	Appoint a Director Aoki, Yoshihisa	Management	For	For
2.13	Appoint a Director Mita, Mayo	Management	For	For
2.14	Appoint a Director Kitachi, Tatsuaki	Management	For	For
3.1	Appoint a Corporate Auditor Toba, Yozo	Management	For	For
3.2	Appoint a Corporate Auditor Sugawara, Hiroshi	Management	For	For
3.3	Appoint a Corporate Auditor Osawa, Kanako	Management	For	For
3.4	Appoint a Corporate Auditor Tsuji, Sachie	Management	For	For

OWENS & MINOR, INC.

Security	690732102	Meeting Type	Annual
Ticker Symbol	OMI	Meeting Date	29-Apr-2022
Record Date	04-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Mark A. Beck	Management	For	For
1.2	Election of Director: Gwendolyn M. Bingham	Management	For	For
1.3	Election of Director: Kenneth Gardner-Smith	Management	For	For
1.4	Election of Director: Robert J. Henkel	Management	For	For
1.5	Election of Director: Stephen W. Klemash	Management	For	For
1.6	Election of Director: Mark F. McGettrick	Management	For	For
1.7	Election of Director: Edward A. Pesicka	Management	For	For
2.	Ratification of the appointment of KPMG LLP as the Company's independent public accounting firm for the year ending December 31, 2022	Management	For	For
3.	Advisory vote to approve the compensation of the Company's named executive officers	Management	For	For
4.	Advisory vote on the frequency of a shareholder vote on the compensation of the Company's named executive officers	Management	1 Year	For

PERKINELMER, INC.

Security	714046109	Meeting Type	Annual
Ticker Symbol	PKI	Meeting Date	26-Apr-2022
Record Date	28-Feb-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director for a term of one year: Peter Barrett, PhD	Management	For	For
1B.	Election of Director for a term of one year: Samuel R. Chapin	Management	For	For
1C.	Election of Director for a term of one year: Sylvie Grégoire, PharmD	Management	For	For
1D.	Election of Director for a term of one year: Alexis P. Michas	Management	For	For
1E.	Election of Director for a term of one year: Prahlad R. Singh, PhD	Management	For	For
1F.	Election of Director for a term of one year: Michel Vounatsos	Management	For	For
1G.	Election of Director for a term of one year: Frank Witney, PhD	Management	For	For
1H.	Election of Director for a term of one year: Pascale Witz	Management	For	For
2.	To ratify the selection of Deloitte & Touche LLP as PerkinElmer's independent registered public accounting firm for the current fiscal year.	Management	For	For
3.	To approve, by non-binding advisory vote, our executive compensation.	Management	For	For

PERRIGO COMPANY PLC

Security	G97822103	Meeting Type	Annual
Ticker Symbol	PRGO	Meeting Date	06-May-2022
Record Date	07-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Bradley A. Alford	Management	For	For
1B.	Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Orlando D. Ashford	Management	For	For
1C.	Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Katherine C. Doyle	Management	For	For
1D.	Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Adriana Karaboutis	Management	For	For
1E.	Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Murray S. Kessler	Management	For	For
1F.	Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Jeffrey B. Kindler	Management	For	For
1G.	Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Erica L. Mann	Management	For	For
1H.	Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Donal O'Connor	Management	For	For
1I.	Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Geoffrey M. Parker	Management	For	For
1J.	Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Theodore R. Samuels	Management	For	For
2.	Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor	Management	For	For
3.	Advisory vote on executive compensation	Management	For	For
4.	Amend the Company's Long-Term Incentive Plan	Management	For	For
5.	Renew the Board's authority to issue shares under Irish law	Management	For	For
6.	Renew the Board's authority to opt-out of statutory pre- emption rights under Irish law	Management	For	For

PFIZER, INC.

Security	717081103	Meeting Type	Annual
Ticker Symbol	PFE	Meeting Date	28-Apr-2022
Record Date	02-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Ronald E. Blaylock	Management	For	For
1B.	Election of Director: Albert Bourla	Management	For	For
1C.	Election of Director: Susan Desmond-Hellmann	Management	For	For
1D.	Election of Director: Joseph J. Echevarria	Management	For	For
1E.	Election of Director: Scott Gottlieb	Management	For	For
1F.	Election of Director: Helen H. Hobbs	Management	For	For
1G.	Election of Director: Susan Hockfield	Management	For	For
1H.	Election of Director: Dan R. Littman	Management	For	For
1I.	Election of Director: Shantanu Narayen	Management	For	For
1J.	Election of Director: Suzanne Nora Johnson	Management	For	For
1K.	Election of Director: James Quincey	Management	For	For
1L.	Election of Director: James C. Smith	Management	For	For
2.	Ratify the selection of KPMG LLP as independent registered public accounting firm for 2022	Management	For	For
3.	2022 advisory approval of executive compensation	Management	For	For
4.	Shareholder proposal regarding amending proxy access	Shareholder	Against	For
5.	Shareholder proposal regarding report on political expenditures congruency	Shareholder	Against	For
6.	Shareholder proposal regarding report on transfer of intellectual property to potential COVID-19 manufacturers	Shareholder	Against	For
7.	Shareholder proposal regarding report on board oversight of risks related to anticompetitive practices	Shareholder	Against	For
8.	Shareholder proposal regarding report on public health costs of protecting vaccine technology	Shareholder	Against	For

PHYSICIANS REALTY TRUST

Security	71943U104	Meeting Type	Annual
Ticker Symbol	DOC	Meeting Date	03-May-2022
Record Date	24-Feb-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Trustee: John T. Thomas	Management	For	For
1.2	Election of Trustee: Tommy G. Thompson	Management	For	For
1.3	Election of Trustee: Stanton D. Anderson	Management	For	For
1.4	Election of Trustee: Mark A. Baumgartner	Management	For	For
1.5	Election of Trustee: Albert C. Black, Jr.	Management	For	For
1.6	Election of Trustee: William A. Ebinger, M.D.	Management	For	For
1.7	Election of Trustee: Pamela J. Kessler	Management	For	For
1.8	Election of Trustee: Ava E. Lias-Booker	Management	For	For
1.9	Election of Trustee: Richard A. Weiss	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.	Management	For	For
3.	To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers.	Management	For	For
4.	To approve, on a non-binding advisory basis, the frequency of casting future votes on the compensation paid to the Company's named executive officers.	Management	1 Year	For

PRIOTHERA LTD.

Security	N/A	Meeting Type	Extraordinary General Meeting
Ticker Symbol	N/A	Meeting Date	28-Sep-2021
Record Date	N/A

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Partial waiver of tranche 2 milestone condition.	Management	For	For

QIAGEN N.V.

Security	N72482123	Meeting Type	Annual
Ticker Symbol	QGEN	Meeting Date	23-Jun-2022
Record Date	26-May-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Proposal to adopt the Annual Accounts for the year ended December 31, 2021 ("Calendar Year 2021").	Management	For	For
2.	Proposal to cast a favorable non-binding advisory vote in respect of the Remuneration Report 2021.	Management	For	For
3.	Proposal to discharge from liability the Managing Directors for the performance of their duties during Calendar Year 2021.	Management	For	For
4.	Proposal to discharge from liability the Supervisory Directors for the performance of their duties during Calendar Year 2021.	Management	For	For
5a.	Reappointment of the Supervisory Director: Dr. Metin Colpan	Management	For	For
5b.	Reappointment of the Supervisory Director: Mr. Thomas Ebeling	Management	For	For
5c.	Reappointment of the Supervisory Director: Dr. Toralf Haag	Management	For	For
5d.	Reappointment of the Supervisory Director: Prof. Dr. Ross L. Levine	Management	For	For
5e.	Reappointment of the Supervisory Director: Prof. Dr. Elaine Mardis	Management	For	For
5f.	Appointment of the Supervisory Director: Dr. Eva Pisa	Management	For	For
5g.	Reappointment of the Supervisory Director: Mr. Lawrence A. Rosen	Management	For	For
5h.	Reappointment of the Supervisory Director: Ms. Elizabeth E. Tallett	Management	For	For
6a.	Reappointment of the Managing Director: Mr. Thierry Bernard	Management	For	For
6b.	Reappointment of the Managing Director: Mr. Roland Sackers	Management	For	For
7.	Proposal to reappoint KPMG Accountants N.V. as auditors of the Company for the calendar year ending December 31, 2022.	Management	For	For
8a.	Proposal to authorize the Supervisory Board, until December 23, 2023 to: issue a number of ordinary shares and financing preference shares and grant rights to subscribe for such shares of up to 50% of the aggregate par value of all shares issued and outstanding.	Management	For	For
8b.	Proposal to authorize the Supervisory Board, until December 23, 2023 to: restrict or exclude the pre- emptive rights with respect to issuing ordinary shares or granting subscription rights of up to 10% of the aggregate par value of all shares issued and outstanding.	Management	For	For
9.	Proposal to authorize the Managing Board, until December 23, 2023, to acquire shares in the Company's own share capital.	Management	For	For
10.	Proposal to approve discretionary rights for the Managing Board to implement a capital repayment by means of a synthetic share repurchase.	Management	For	For
11.	Proposal to approve the cancellation of fractional shares held by the Company.	Management	For	For

R1 RCM, INC.

Security	749397105	Meeting Type	Annual
Ticker Symbol	RCM	Meeting Date	26-May-2022
Record Date	06-Apr-2022

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1.	Agnes Bundy Scanlan		For	For
	2.	David M. Dill		For	For
	3.	Michael C. Feiner		For	For
	4.	Joseph Flanagan		For	For
	5.	John B. Henneman III		For	For
	6.	Neal Moszkowski		For	For
	7.	Ian Sacks		For	For
	8.	Jill Smith		For	For
	9.	Anthony J. Speranzo		For	For
	10.	Anthony R. Tersigni		For	For
	11.	Albert R. Zimmerli		For	For
2.	To approve, for purposes of complying with the applicable provisions of Nasdaq Listing Rule 5635, the issuance of shares of common stock of Project Roadrunner Parent Inc. ("New R1") to CoyCo 1, L.P. and CoyCo 2, L.P., pursuant to the terms of the Transaction Agreement and Plan of Merger, dated as of January 9, 2022, by and among the Company, New R1, Project Roadrunner Merger Sub Inc., Revint Holdings, LLC ("Cloudmed"), CoyCo 1, L.P., CoyCo 2., L.P., and certain other parties, as described in the accompanying proxy statement/prospectus.		Management	For	For
3.	To approve the adoption of an amendment to the Company's Restated Certificate of Incorporation to increase our authorized share capital from 500,000,000 shares to 750,000,000 shares of common stock.		Management	For	For
4.	To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.		Management	For	For
5.	To approve the adjournment of the 2022 Annual Meeting to a later date, or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of one or more proposals at the 2022 Annual Meeting.		Management	For	For

REGENERON PHARMACEUTICALS, INC.

Security	75886F107	Meeting Type	Annual
Ticker Symbol	REGN	Meeting Date	10-Jun-2022
Record Date	12-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Bonnie L. Bassler, Ph.D.	Management	For	For
1b.	Election of Director: Michael S. Brown, M.D.	Management	For	For
1c.	Election of Director: Leonard S. Schleifer, M.D., Ph.D.	Management	For	For
1d.	Election of Director: George D. Yancopoulos, M.D., Ph.D.	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.	Management	For	For
3.	Proposal to approve, on an advisory basis, executive compensation.	Management	For	For

RESMED, INC.

Security	761152107	Meeting Type	Annual
Ticker Symbol	RMD	Meeting Date	18-Nov-2021
Record Date	21-Sep-2021

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Re-election of Director to serve until 2022 annual meeting: Karen Drexler	Management	For	For
1B.	Re-election of Director to serve until 2022 annual meeting: Michael Farrell	Management	For	For
1C.	Re-election of Director to serve until 2022 annual meeting: Peter Farrell	Management	For	For
1D.	Re-election of Director to serve until 2022 annual meeting: Harjit Gill	Management	For	For
1E.	Re-election of Director to serve until 2022 annual meeting: Ron Taylor	Management	For	For
1F.	Election of Director to serve until 2022 annual meeting: John Hernandez	Management	For	For
1G.	Election of Director to serve until 2022 annual meeting: Desney Tan	Management	For	For
2.	Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2022.	Management	For	For
3.	Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay").	Management	For	For

SABRA HEALTH CARE REIT, INC.

Security	78573L106	Meeting Type	Annual
Ticker Symbol	SBRA	Meeting Date	14-Jun-2022
Record Date	18-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Craig A. Barbarosh	Management	For	For
1b.	Election of Director: Katie Cusack	Management	For	For
1c.	Election of Director: Michael J. Foster	Management	For	For
1d.	Election of Director: Lynne S. Katzmann	Management	For	For
1e.	Election of Director: Ann Kono	Management	For	For
1f.	Election of Director: Jeffrey A. Malehorn	Management	For	For
1g.	Election of Director: Richard K. Matros	Management	For	For
1h.	Election of Director: Clifton J. Porter II	Management	For	For
2.	Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2022.	Management	For	For
3.	Approval, on an advisory basis, of the compensation of Sabra's named executive officers.	Management	For	For

SANOFI

Security	80105N105	Meeting Type	Annual
Ticker Symbol	SNY	Meeting Date	03-May-2022
Record Date	04-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
O1	Approval of the individual company financial statements for the year ended December 31, 2021	Management	For	For
O2	Approval of the consolidated financial statements for the year ended December 31, 2021	Management	For	For
O3	Appropriation of profits for the year ended December 31, 2021 and declaration of dividend	Management	For	For
O4	Reappointment of Paul Hudson as Director	Management	For	For
O5	Reappointment of Christophe Babule as Director	Management	For	For
O6	Reappointment of Patrick Kron as Director	Management	For	For
O7	Reappointment of Gilles Schnepp as Director	Management	For	For
O8	Appointment of Carole Ferrand as Director	Management	For	For
O9	Appointment of Emile Voest as Director	Management	For	For
O10	Appointment of Antoine Yver as Director	Management	For	For
O11	Approval of the report on the compensation of corporate officers issued in accordance with Article L. 22-10-9 of the French Commercial Code	Management	For	For
O12	Approval of the components of the compensation paid or awarded in respect of the year ended December 31, 2021 to Serge Weinberg, Chairman of the Board	Management	For	For
O13	Approval of the components of the compensation paid or awarded in respect of the year ended December 31, 2021 to Paul Hudson, Chief Executive Officer	Management	For	For
O14	Approval of the compensation policy for directors	Management	For	For
O15	Approval of the compensation policy for the Chairman of the Board of Directors	Management	For	For
O16	Approval of the compensation policy for the Chief Executive Officer	Management	For	For
O17	Authorization to the Board of Directors to carry out transactions in the Company's shares (usable outside the period of a public tender offer)	Management	For	For
E18	Amendment to Article 25 of the Company's Articles of Association - Dividends	Management	For	For
19	Powers for formalities	Management	For	For

SHIONOGI & CO.,LTD.

Security	J74229105	Meeting Type	Annual General Meeting
Ticker Symbol	4507 JP	Meeting Date	23-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approve Appropriation of Surplus	Management	For	For
2.	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations	Management	For	For
3.1	Appoint a Director Teshirogi, Isao	Management	For	For
3.2	Appoint a Director Sawada, Takuko	Management	For	For
3.3	Appoint a Director Ando, Keiichi	Management	For	For
3.4	Appoint a Director Ozaki, Hiroshi	Management	For	For
3.5	Appoint a Director Takatsuki, Fumi	Management	For	For
4.	Approve Disposal of Own Shares to a Third Party or Third Parties	Management	For	For

SMITH & NEPHEW PLC

Security	83175M205	Meeting Type	Annual
Ticker Symbol	SNN	Meeting Date	13-Apr-2022
Record Date	22-Feb-2022

Item	Proposal	Proposed by	Vote	For/Against Management
O1	To receive the audited accounts	Management	For	For
O2	To approve the Directors' Remuneration Report (excluding policy)	Management	For	For
O3	To declare a final dividend	Management	For	For
O4	ELECTION AND RE-ELECTION OF DIRECTOR: Erik Engstrom	Management	For	For
O5	ELECTION AND RE-ELECTION OF DIRECTOR: Robin Freestone	Management	For	For
O6	ELECTION AND RE-ELECTION OF DIRECTOR: Jo Hallas	Management	For	For
O7	ELECTION AND RE-ELECTION OF DIRECTOR: John Ma	Management	For	For
O8	ELECTION AND RE-ELECTION OF DIRECTOR: Katarzyna Mazur-Hofsaess	Management	For	For
O9	ELECTION AND RE-ELECTION OF DIRECTOR: Rick Medlock	Management	For	For
O10	ELECTION AND RE-ELECTION OF DIRECTOR: Deepak Nath	Management	For	For
O11	ELECTION AND RE-ELECTION OF DIRECTOR: Anne- Françoise Nesmes	Management	For	For
O12	ELECTION AND RE-ELECTION OF DIRECTOR: Marc Owen	Management	For	For
O13	ELECTION AND RE-ELECTION OF DIRECTOR: Roberto Quarta	Management	For	For
O14	ELECTION AND RE-ELECTION OF DIRECTOR: Angie Risley	Management	For	For
O15	ELECTION AND RE-ELECTION OF DIRECTOR: Bob White	Management	For	For
O16	To re-appoint the Auditor	Management	For	For
O17	To authorise Directors' to determine the remuneration of the Auditor	Management	For	For
O18	To renew the Directors' authority to allot shares	Management	For	For
O19	To approve the Smith+Nephew Sharesave Plan (2022)	Management	For	For
O20	To approve the Smith+Nephew International Sharesave Plan (2022)	Management	For	For
S21	To renew the Directors' authority for the disapplication of the pre-emption rights	Management	For	For
S22	To authorise the Directors' to disapply pre-emption rights for the purposes of acquisitions or other capital investments	Management	For	For
S23	To renew the Directors' limited authority to make market purchases of the Company's own shares	Management	For	For
S24	To authorise general meetings to be held on 14 clear days' notice	Management	For	For

STERIS PLC

Security	G8473T100	Meeting Type	Annual
Ticker Symbol	STE	Meeting Date	29-Jul-2021
Record Date	01-Jun-2021

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Re-election of Director: Richard C. Breeden	Management	For	For
1B.	Re-election of Director: Daniel A. Carestio	Management	For	For
1C.	Re-election of Director: Cynthia L. Feldmann	Management	For	For
1D.	Re-election of Director: Christopher Holland	Management	For	For
1E.	Re-election of Director: Dr. Jacqueline B. Kosecoff	Management	For	For
1F.	Re-election of Director: Paul E. Martin	Management	For	For
1G.	Re-election of Director: Dr. Nirav R. Shah	Management	For	For
1H.	Re-election of Director: Dr. Mohsen M. Sohi	Management	For	For
1I.	Re-election of Director: Dr. Richard M. Steeves	Management	For	For
2.	To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2022.	Management	For	For
3.	To appoint Ernst & Young Chartered Accountants as the Company's Irish statutory auditor under the Act to hold office until the conclusion of the Company's next Annual General Meeting.	Management	For	For
4.	To authorize the Directors of the Company or the Audit Committee to determine the remuneration of Ernst & Young Chartered Accountants as the Company's Irish statutory auditor.	Management	For	For
5.	To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 14, 2021.	Management	For	For

STEVANATO GROUP S.P.A

Security	T9224W109	Meeting Type	Annual
Ticker Symbol	STVN	Meeting Date	01-Jun-2022
Record Date	06-May-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approval of the financial statements for the financial year ended on December 31, 2021, and acknowledgment of the related statements and reports.	Management	For
2.	Allocation of annual net profits; distribution of a gross dividend in cash of Euro 0.051 for each outstanding share, net of the treasury shares and related resolutions.	Management	For
3.	Approval of the yearly gross total compensation of Euro 148,000, to be paid partly in cash and partly in shares, for each Director (except for Mr. Franco Moro).	Management	For
4.	Appointment of EY S.p.A. for the auditing of the 2021 and 2022 financial statements according to the PCOAB standards and grant of the relevant additional annual compensation.	Management	For
5.	Grant to the Board of Directors of the authorization to purchase, and dispose of, treasury shares within certain limitations for a one-year period and related resolutions.	Management	For
6.	Approval of amendments to Articles 21.2 and 25.2 of the Bylaws and related resolutions.	Management	For

STRYKER CORPORATION

Security	863667101	Meeting Type	Annual
Ticker Symbol	SYK	Meeting Date	04-May-2022
Record Date	07-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A)	Election of Director: Mary K. Brainerd	Management	For	For
1B)	Election of Director: Giovanni Caforio, M.D.	Management	For	For
1C)	Election of Director: Srikant M. Datar, Ph.D.	Management	For	For
1D)	Election of Director: Allan C. Golston (Lead Independent Director)	Management	For	For
1E)	Election of Director: Kevin A. Lobo (Chair of the Board, Chief Executive Officer and President)	Management	For	For
1F)	Election of Director: Sherilyn S. McCoy	Management	For	For
1G)	Election of Director: Andrew K. Silvernail	Management	For	For
1H)	Election of Director: Lisa M. Skeete Tatum	Management	For	For
1I)	Election of Director: Ronda E. Stryker	Management	For	For
1J)	Election of Director: Rajeev Suri	Management	For	For
2)	Ratification of Appointment of our Independent Registered Public Accounting Firm.	Management	For	For
3)	Advisory Vote to Approve Named Executive Officer Compensation.	Management	For	For
4)	Shareholder Proposal to Amend Proxy Access Terms.	Shareholder	Against	For

SYSMEX CORPORATION

Security	J7864H102	Meeting Type	Annual General Meeting
Ticker Symbol	6869 JP	Meeting Date	24-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approve Appropriation of Surplus	Management	For	For
2.	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations	Management	For	For
3.1	Appoint a Director who is not Audit and Supervisory Committee Member Ietsugu, Hisashi	Management	For	For
3.2	Appoint a Director who is not Audit and Supervisory Committee Member Asano, Kaoru	Management	For	For
3.3	Appoint a Director who is not Audit and Supervisory Committee Member Tachibana, Kenji	Management	For	For
3.4	Appoint a Director who is not Audit and Supervisory Committee Member Matsui, Iwane	Management	For	For
3.5	Appoint a Director who is not Audit and Supervisory Committee Member Kanda, Hiroshi	Management	For	For
3.6	Appoint a Director who is not Audit and Supervisory Committee Member Yoshida, Tomokazu	Management	For	For
3.7	Appoint a Director who is not Audit and Supervisory Committee Member Takahashi, Masayo	Management	For	For
3.8	Appoint a Director who is not Audit and Supervisory Committee Member Ota, Kazuo	Management	For	For
3.9	Appoint a Director who is not Audit and Supervisory Committee Member Fukumoto, Hidekazu	Management	For	For
4.1	Appoint a Director who is Audit and Supervisory Committee Member Aramaki, Tomoo	Management	For	For
4.2	Appoint a Director who is Audit and Supervisory Committee Member Hashimoto, Kazumasa	Management	For	For
4.3	Appoint a Director who is Audit and Supervisory Committee Member Iwasa, Michihide	Management	For	For

TAKEDA PHARMACEUTICAL CO LTD

Security	874060205	Meeting Type	Annual
Ticker Symbol	TAK	Meeting Date	29-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Appropriation of Surplus	Management	For	For
2.	Partial Amendment to the Articles of Incorporation	Management	For	For
3a.	Election of Director who is not Audit and Supervisory Committee Member: Christophe Weber	Management	For	For
3b.	Election of Director who is not Audit and Supervisory Committee Member: Masato Iwasaki	Management	For	For
3c.	Election of Director who is not Audit and Supervisory Committee Member: Andrew Plump	Management	For	For
3d.	Election of Director who is not Audit and Supervisory Committee Member: Costa Saroukos	Management	For	For
3e.	Election of Director who is not Audit and Supervisory Committee Member: Olivier Bohuon	Management	For	For
3f.	Election of Director who is not Audit and Supervisory Committee Member: Jean-Luc Butel	Management	For	For
3g.	Election of Director who is not Audit and Supervisory Committee Member: Ian Clark	Management	For	For
3h.	Election of Director who is not Audit and Supervisory Committee Member: Steven Gillis	Management	For	For
3i.	Election of Director who is not Audit and Supervisory Committee Member: Masami Iijima	Management	For	For
3j.	Election of Director who is not Audit and Supervisory Committee Member: John Maraganore	Management	For	For
3k.	Election of Director who is not Audit and Supervisory Committee Member: Michel Orsinger	Management	For	For
4a.	Election of Director who is Audit and Supervisory Committee Member: Koji Hatsukawa	Management	For	For
4b.	Election of Director who is Audit and Supervisory Committee Member: Emiko Higashi	Management	For	For
4c.	Election of Director who is Audit and Supervisory Committee Member: Yoshiaki Fujimori	Management	For	For
4d.	Election of Director who is Audit and Supervisory Committee Member: Kimberly A. Reed	Management	For	For

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Security	J8129E108	Meeting Type	Annual General Meeting
Ticker Symbol	4502 JP	Meeting Date	29-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approve Appropriation of Surplus	Management	For	For
2.	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations	Management	For	For
3.1	Appoint a Director who is not Audit and Supervisory Committee Member Christophe Weber	Management	For	For
3.2	Appoint a Director who is not Audit and Supervisory Committee Member Iwasaki, Masato	Management	For	For
3.3	Appoint a Director who is not Audit and Supervisory Committee Member Andrew Plump	Management	For	For
3.4	Appoint a Director who is not Audit and Supervisory Committee Member Constantine Saroukos	Management	For	For
3.5	Appoint a Director who is not Audit and Supervisory Committee Member Olivier Bohuon	Management	For	For
3.6	Appoint a Director who is not Audit and Supervisory Committee Member Jean-Luc Butel	Management	For	For
3.7	Appoint a Director who is not Audit and Supervisory Committee Member Ian Clark	Management	For	For
3.8	Appoint a Director who is not Audit and Supervisory Committee Member Steven Gillis	Management	For	For
3.9	Appoint a Director who is not Audit and Supervisory Committee Member Iijima, Masami	Management	For	For
3.10	Appoint a Director who is not Audit and Supervisory Committee Member John Maraganore	Management	For	For
3.11	Appoint a Director who is not Audit and Supervisory Committee Member Michel Orsinger	Management	For	For
4.1	Appoint a Director who is Audit and Supervisory Committee Member Hatsukawa, Koji	Management	For	For
4.2	Appoint a Director who is Audit and Supervisory Committee Member Higashi, Emiko	Management	For	For
4.3	Appoint a Director who is Audit and Supervisory Committee Member Fujimori, Yoshiaki	Management	For	For
4.4	Appoint a Director who is Audit and Supervisory Committee Member Kimberly Reed	Management	For	For
5.	Approve Payment of Bonuses to Directors (Excluding Directors who are Audit and Supervisory Committee Members)	Management	For	For

TERUMO CORPORATION

Security	J83173104	Meeting Type	Annual General Meeting
Ticker Symbol	4543 JP	Meeting Date	22-Jun-2022
Record Date	31-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.	Approve Appropriation of Surplus	Management	For	For
2.	Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations	Management	For	For
3.1	Appoint a Director who is not Audit and Supervisory Committee Member Takagi, Toshiaki	Management	For	For
3.2	Appoint a Director who is not Audit and Supervisory Committee Member Sato, Shinjiro	Management	For	For
3.3	Appoint a Director who is not Audit and Supervisory Committee Member Hatano, Shoji	Management	For	For
3.4	Appoint a Director who is not Audit and Supervisory Committee Member Nishikawa, Kyo	Management	For	For
3.5	Appoint a Director who is not Audit and Supervisory Committee Member Hirose, Kazunori	Management	For	For
3.6	Appoint a Director who is not Audit and Supervisory Committee Member Kuroda, Yukiko	Management	For	For
3.7	Appoint a Director who is not Audit and Supervisory Committee Member Nishi, Hidenori	Management	For	For
3.8	Appoint a Director who is not Audit and Supervisory Committee Member Ozawa, Keiya	Management	For	For
4.	Appoint a Substitute Director who is Audit and Supervisory Committee Member Sakaguchi, Koichi	Management	For	For

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Security	881624209	Meeting Type	Annual
Ticker Symbol	TEVA	Meeting Date	23-Jun-2022
Record Date	16-May-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Amir Elstein	Management	For	For
1b.	Election of Director: Roberto A. Mignone	Management	For	For
1c.	Election of Director: Dr. Perry D. Nisen	Management	For	For
1d.	Election of Director: Dr. Tal Zaks	Management	For	For
2.	To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers.	Management	For	For
3.	To approve Teva's Compensation Policy with respect to the Terms of Office and Employment of Teva's Executive Officers and Directors.	Management	For	For
3A.	Regarding proposal 3, please indicate when you vote whether or not you are a controlling shareholder of Teva and whether or not you have a personal benefit or other interest in this proposal* Mark "for" = yes or "against" = no.	Management	Against	N/A
4.	To approve amendments to Teva's Articles of Association.	Management	For	For
5.	To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2023 annual meeting of shareholders.	Management	For	For

THE SELECT SECTOR SPDR TRUST

Security	81369Y209	Meeting Type	Special
Ticker Symbol	XLV	Meeting Date	29-Oct-2021
Record Date	03-Sep-2021

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1.	Allison Grant Williams		For	For
	2.	Sheila Hartnett-Devlin		For	For
	3.	James Jessee		For	For
	4.	Teresa Polley		For	For
	5.	Ashley T. Rabun		For	For
	6.	James E. Ross		For	For
	7.	Rory Tobin		For	For

THERMO FISHER SCIENTIFIC, INC.

Security	883556102	Meeting Type	Annual
Ticker Symbol	TMO	Meeting Date	18-May-2022
Record Date	25-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of director: Marc N. Casper	Management	For	For
1B.	Election of director: Nelson J. Chai	Management	For	For
1C.	Election of director: Ruby R. Chandy	Management	For	For
1D.	Election of director: C. Martin Harris	Management	For	For
1E.	Election of director: Tyler Jacks	Management	For	For
1F.	Election of director: R. Alexandra Keith	Management	For	For
1G.	Election of director: Jim P. Manzi	Management	For	For
1H.	Election of director: James C. Mullen	Management	For	For
1I.	Election of director: Lars R. Sorensen	Management	For	For
1J.	Election of director: Debora L. Spar	Management	For	For
1K.	Election of director: Scott M. Sperling	Management	For	For
1L.	Election of director: Dion J. Weisler	Management	For	For
2.	An advisory vote to approve named executive officer compensation.	Management	For	For
3.	Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2022.	Management	For	For

UNIVERSAL HEALTH REALTY INCOME TRUST

Security	91359E105	Meeting Type	Annual
Ticker Symbol	UHT	Meeting Date	08-Jun-2022
Record Date	11-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Trustee: Michael Allan Domb	Management	For	For
1.2	Election of Trustee: James P. Morey	Management	For	For
2.	Advisory (nonbinding) vote to approve named executive officer compensation.	Management	For	For
3.	To ratify the selection of KPMG, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.	Management	For	For

UNITEDHEALTH GROUP, INC.

Security	91324P102	Meeting Type	Annual
Ticker Symbol	UNH	Meeting Date	06-Jun-2022
Record Date	08-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1a.	Election of Director: Timothy P. Flynn	Management	For	For
1b.	Election of Director: Paul R. Garcia	Management	For	For
1c.	Election of Director: Stephen J. Hemsley	Management	For	For
1d.	Election of Director: Michele J. Hooper	Management	For	For
1e.	Election of Director: F. William McNabb III	Management	For	For
1f.	Election of Director: Valerie C. Montgomery Rice, M.D.	Management	For	For
1g.	Election of Director: John H. Noseworthy, M.D.	Management	For	For
1h.	Election of Director: Andrew Witty	Management	For	For
2.	Advisory approval of the Company's executive compensation.	Management	For	For
3.	Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2022.	Management	For	For
4.	If properly presented at the 2022 Annual Meeting of Shareholders, the shareholder proposal seeking shareholder ratification of termination pay.	Shareholder	Against	For
5.	If properly presented at the 2022 Annual Meeting of Shareholders, the shareholder proposal regarding political contributions congruency report.	Shareholder	Against	For

VENTAS, INC.

Security	92276F100	Meeting Type	Contested-Annual
Ticker Symbol	VTR	Meeting Date	27-Apr-2022
Record Date	21-Mar-2022

Item	Proposal		Proposed by	Vote	For/Against Management
1.	DIRECTOR		Management
	1.	Melody C. Barnes		For	For
	2.	Debra A. Cafaro		For	For
	3.	Michael J. Embler		For	For
	4.	Matthew J. Lustig		For	For
	5.	Roxanne M. Martino		For	For
	6.	Marguerite M. Nader		For	For
	7.	Sean P. Nolan		For	For
	8.	Walter C. Rakowich		For	For
	9.	Robert D. Reed		For	For
	10.	James D. Shelton		For	For
	11.	Maurice S. Smith		For	For
2.	Proposal to approve, on an advisory basis, the compensation of our Named Executive Officers.		Management	For	For
3.	Proposal to approve the Ventas, Inc. 2022 Incentive Plan.		Management	For	For
4.	Proposal to ratify KPMG LLP as our independent registered public accounting firm for the 2022 fiscal year.		Management	For	For

VERONA PHARMA PLC

Security	925050106	Meeting Type	Annual
Ticker Symbol	VRNA	Meeting Date	27-Apr-2022
Record Date	15-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
O1	To re-elect Kenneth Cunningham, M.D. as a director of the Company	Management	For	For
O2	To re-elect Rishi Gupta as a director of the Company	Management	For	For
O3	To re-elect Vikas Sinha as a director of the Company	Management	For	For
O4	To re-elect James Brady as a director of the Company	Management	For	For
O5	To receive and adopt the 2021 U.K. Annual Report	Management	For	For
O6	To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors' Remuneration Report	Management	For	For
O7	To re-appoint PwC as the Company's auditors, to hold office until the conclusion of the next annual general meeting of shareholders	Management	For	For
O8	To authorize the Audit and Risk Committee to determine the auditors' remuneration for the year ending December 31, 2022	Management	For	For
O9	To authorize the Board of Directors to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of £24,702,912	Management	For	For
E10	To authorize the Board of Directors to allot equity securities for cash and/or to sell ordinary shares held by the Company as treasury shares for cash as if Section 561(1) of the Companies Act does not apply to any such allotment	Management	For	For

WATERS CORPORATION

Security	941848103	Meeting Type	Annual
Ticker Symbol	WAT	Meeting Date	24-May-2022
Record Date	25-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1.1	Election of Director: Dr. Udit Batra, Ph.D.	Management	For	For
1.2	Election of Director: Linda Baddour	Management	For	For
1.3	Election of Director: Edward Conard	Management	For	For
1.4	Election of Director: Dr. Pearl S. Huang, Ph.D.	Management	For	For
1.5	Election of Director: Wei Jiang	Management	For	For
1.6	Election of Director: Christopher A. Kuebler	Management	For	For
1.7	Election of Director: Dr. Flemming Ornskov, M.D., M.P.H.	Management	For	For
1.8	Election of Director: Thomas P. Salice	Management	For	For
2.	To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.	Management	For	For
3.	To approve, by non-binding vote, executive compensation.	Management	For	For

WELLTOWER, INC.

Security	95040Q104	Meeting Type	Annual
Ticker Symbol	WELL	Meeting Date	23-May-2022
Record Date	04-Apr-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Kenneth J. Bacon	Management	For	For
1B.	Election of Director: Karen B. DeSalvo	Management	For	For
1C.	Election of Director: Philip L. Hawkins	Management	For	For
1D.	Election of Director: Dennis G. Lopez	Management	For	For
1E.	Election of Director: Shankh Mitra	Management	For	For
1F.	Election of Director: Ade J. Patton	Management	For	For
1G.	Election of Director: Diana W. Reid	Management	For	For
1H.	Election of Director: Sergio D. Rivera	Management	For	For
1I.	Election of Director: Johnese M. Spisso	Management	For	For
1J.	Election of Director: Kathryn M. Sullivan	Management	For	For
2.	To amend the Certificate of Incorporation of Welltower OP Inc. to remove the provision requiring Welltower Inc. shareholders to approve amendments to the Welltower OP Inc. Certificate of Incorporation and other extraordinary transactions involving Welltower OP Inc.	Management	For	For
3.	The ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2022.	Management	For	For
4.	The approval, on an advisory basis, of the compensation of our named executive officers as disclosed in the 2022 Proxy Statement.	Management	For	For

ZIMMER BIOMET HOLDINGS, INC.

Security	98956P102	Meeting Type	Annual
Ticker Symbol	ZBH	Meeting Date	13-May-2022
Record Date	14-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Christopher B. Begley	Management	For	For
1B.	Election of Director: Betsy J. Bernard	Management	For	For
1C.	Election of Director: Michael J. Farrell	Management	For	For
1D.	Election of Director: Robert A. Hagemann	Management	For	For
1E.	Election of Director: Bryan C. Hanson	Management	For	For
1F.	Election of Director: Arthur J. Higgins	Management	For	For
1G.	Election of Director: Maria Teresa Hilado	Management	For	For
1H.	Election of Director: Syed Jafry	Management	For	For
1I.	Election of Director: Sreelakshmi Kolli	Management	For	For
1J.	Election of Director: Michael W. Michelson	Management	For	For
2.	Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2022.	Management	For	For
3.	Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay").	Management	For	For

ZOETIS, INC.

Security	98978V103	Meeting Type	Annual
Ticker Symbol	ZTS	Meeting Date	19-May-2022
Record Date	25-Mar-2022

Item	Proposal	Proposed by	Vote	For/Against Management
1A.	Election of Director: Paul M. Bisaro	Management	For	For
1B.	Election of Director: Frank A. D'Amelio	Management	For	For
1C.	Election of Director: Michael B. McCallister	Management	For	For
2.	Advisory vote to approve our executive compensation.	Management	For	For
3.	Approval of an Amendment and Restatement of our 2013 Equity and Incentive Plan.	Management	For	For
4.	Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2022.	Management	For	For
5.	Approval of an amendment to our Restated Certificate of Incorporation to eliminate supermajority voting provisions and certain provisions related to Pfizer Inc.	Management	For	For
6.	Approval of an amendment to our Restated Certificate of Incorporation to declassify the Board of Directors.	Management	For	For

SIGNATURES

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)		Tekla World Healthcare Fund
By (Signature and Title)*
			/s/ Daniel R. Omstead
			(Daniel R. Omstead, President)
Date	8/19/22

*Print the name and title of each signing officer under his or her signature.